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Figure 1.1: Schematic showing phases of the cell cycle including quiescence. 
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Figure 1.2: Schematic showing formation of the pre-Replication complex (pre-RC) 
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C-terminal region – NM binding N-terminal region - DNA replication 




Figure 1.3: Map of the CIZ1 protein showing motifs and location of interaction sites. 
Gluatamin-rich domains (QD, white), zinc fingers (ZF, dark red), acidic domain (AD, 
green), matrin 3 domain (MH3, pink) taken from Mitsui et al., 1999. Nuclear 
localisation sequences (NLS, yellow) from D. Coverley, personal communication. 
Cyclin binding motif (Cy, black) taken from Copeland et al., 2012. CDK 
phosphorylation sites, where phosphorylation causes negative regulation taken 
from Coverley et al., 2002 (red stars), other putative CDK phosphorylation sites 
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Figure 1.4: Newly synthesised DNA is located at the NM A) Left: Example of 
Maximum Fluorescence Halo Radius image from NIH3T3 cell showing DNA loops 
stained with DAPI emanating out from attachment points in the residual nucleus 
(RN) (MFHR method described in Buongiorno-Nardelli et al., 1982; Guillou et al., 
2010). Right: Newly synthesised DNA is observed at the NM but not visible in loop 
DNA. Cells were pulsed for 30 minutes with BrdU and visualised with !-BrdU. 
Centre: Merged image showing BrdU (newly synthesised DNA) in white and DNA in 
magenta. 
  
Previously published in Wilson and Coverley, 2013. 
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Figure 1.5: Arrangement of DNA by attachment to the NM with intervening loops. A) 
DNA is thought to be periodically attached to the NM at S/MARs forming intervening 
chromatin loops. B) Refined model illustrating variable loop sizes, and complex 
S/MAR usage including utilised S/MARs and function-related alternative potential 
S/MARs.  
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Figure 3.1: Definition of MFHR terms. Example MFHR image showing RN and halo, 
indicating RN and outer thresholds. Note that automatic measurement of thresholds 
(derived from area measurements) compensate for non-spherical nuclei (see later).  
 
Please note: The outer threshold in particular, reproduces better on screen than in 
print. I have chosen not to contrast enhance these images for print copies as this 
would visually change the RN threshold. Please see the accompanying DVD to 
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// Ask user for source and destination directories 
dir = getDirectory("Roses Source Directory"); 
dest1 = getDirectory("Roses Destination Directory"); 
dest2 = getDirectory("Roses Destination2 Directory"); 
 
list = getFileList(dir); 
setBatchMode(true); 
 
for (i=0; i<list.length; i++) { 
         name = list[i]; 
         path = dir + name; 
 
        // Open image 
        open(path); 
 // Macro 
 run("Find Maxima...", "noise=55 output=[Maxima Within Tolerance]"); 
 run("Close-"); 
 //run("Threshold..."); 
 setThreshold(255, 255); 
 run("Convert to Mask"); 
 run("Analyze Particles...", "size=3000-Infinity pixel circularity=0.00-1.00 show=Outlines display 
exclude"); 
 //  




 run("Find Maxima...", "noise=240 output=[Maxima Within Tolerance]"); 
 run("Close-"); 
 //run("Threshold..."); 
 setThreshold(255, 255); 
 run("Convert to Mask"); 
 run("Analyze Particles...", "size=3000-Infinity circularity=0.00-1.00 show=Outlines display exclude"); 





        // Clean up 
        selectWindow(name); 
        close(); 
} 
Figure 3.2: Explanation of HIM for ImageJ. A) Images show visual representation of 
the steps within the macro. B) ImageJ HIM macro script. File name: Halo 55 240, 
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Figure 3.3: Exposure settings for MFHR images. A) Cells transfected with EGFP-
CIZ1 C-term274 (green) were imaged for MFHR at multiple exposures. B) RN areas 
were calculated using the ImageJ polygon function as shown in the lower image 
and radius measurements calculated using the formula shown. C) Left: Graph 
shows calculated radius as a percentage of that from EGFP-CIZ1 C-term274 image 
for each of 16 cells as a function of exposure time. Right: Histogram shows 
averages from the same cells. Far right: Table shows values for average 
percentage of EGFP-CIZ1 C-term274 radius measurement.  
A 
EGFP-CIZ1 
C-term274       Exposure:        3ms                   4ms                   5ms                  6ms                   10ms  
radius of RN (µm)=  
 
(!((Area of RN/10000)/"))/P 
 
 





























































































Figure 3.4: Determination of RN and outer thresholds. A) Left: Image shows a 5 ms 
MFHR image. Right: RN area analysis pictures from the HIM are shown for the 
indicated pixel intensity thresholds. B) Graph shows HIM calculated RN radius as a 
percentage of visual radius calculated from MFHR image for each of 16 cells. 
Histogram shows averages from the same cell set. Table shows values for average 
percentage of visual radius measurement. C) MFHR image and outer threshold 
analysis pictures from HIM for the indicated pixel intensity thresholds. D) Histogram 
shows average HIM calculated halo radius using the indicated outer thresholds 
from 38 cells expressed in µm. Centre: Graph shows HIM calculated halo radius 
measurements for the indicated outer thresholds as a percentage of those 
calculated for 3T3 cells by Vogelstein et al. (1980). Right: Graph shows the effect 
on halo radius when using different combinations of thresholds.  
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Figure 3.5 Halos are not due to flare. A) Frequency distribution of halo radii of cells 
treated with standard MFHR (2.0 M NaCl) or with only 0.5 M NaCl to produce a 
bright object to test for effect of flare. B) Average halo radius for cell sets described 
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Figure 3.6: Options to calculate halo radius from ImageJ area measurements. A) 
Schematic of circular MFHR image showing total and RN radii. B) Formulae are 
shown to determine halo radius assuming the areas are squares, circles, or 
ellipses. C) Schematic of an elliptical MFHR image showing major and minor 
measurements. D) Histogram showing halo radius calculated using the three 



















Radius C = (!((Area C/A)")) 
Radius T = (!((Area T/A)")) 
Halo radius µm = (Radius T – Radius C)/P 












Average Halo = Average (Halo Major:Halo Minor) 
Halo Major = (Major A – Major a)/2 
Halo Minor = (Minor B – Minor b)/2 
Fit to ellipse: 
Halo µm = ((Average Halo)/L)/P 
Diameter C = !(Area C/A) 
Diameter T = !(Area T/A) 
Halo radius µm = (Radius T – Radius C)/P 
Fit to square: 
Radius C = Diameter C/2 
Radius T = Diameter T/2 
A = area conversion factor between Openlab and ImageJ = 10000 
P = conversion factor between pixels and µm = 9.5238  
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Figure 3.7: Comparison of RN, total and halo radii. A) Images showing MFHR, RN 
and outer threshold analysis pictures and combined image showing three radius 
measurements. B) Average radii measurements for a set of 33 cells. C) Frequency 
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Halo radius (µm) 
Figure 3.8: Comparison of measurements by eye and HIM. A) Left: Histogram 
shows average halo radius calculated for two sets of cells (A, B) collected at 5 ms 
exposure. Right: Frequency distribution of halo radius data of A and B by eye and 
by HIM. B) Left: Histogram showing pixel intensities across a traverse of a 
representative MFHR image (right). Arrow heads indicate extents of the line (I, VI) 
and boundaries determined by HIM using the 55-240 threshold combination. The 
RN threshold is at III and IV and outer threshold at II and V. C) Histogram shows 
average halo radius calculated for four sets of cells (A-D) either by eye using 
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MEF 15.86 9.23 1.72 1.67 
E null 14.89 9.23 1.61  
Figure 3.9: HIM adjustments for Mesenchymal Stem Cells (Funes et al., 2007) and 
cyclin E null cells (Geng et al., 2003). A) Graph shows percentage of cells which 
have a measurable halo using different outer thresholds for MSCh1 and MSCh3 
lines. B) Graph shows HIM RN area calculations using different RN thresholds as 
percentage of visual calculation, for MSCh1 and MSCh3 cell lines. C) Histogram 
shows halo radii calculated using different pairs of HIM thresholds. D) Table shows 
average halo radius for control MEF and cyclin E null MEF cell lines calculated by 
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Figure 3.10: HIM adjustments for DAPI MFHR (fixed cells). A) Left: Graph shows 
halo radius for a bright (class I) and pale (class II) cell from DAPI fixed MFHR 
images. Class definitions are given in section 3.4.6. The class II cell was unable to 
be measured at less than 14ms, at 14 ms a measurement was generated but two 
cells were joined. Right: Graph shows RN radius for the same cells. B) Graph 
shows percentage of RNs measurable at different RN thresholds. C) Graph shows 
RN radius as percentage of visual radius at different RN thresholds for a set of cells 
including or excluding pale cells (class II). D) Histogram shows average halo radius 
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Figure 3.11: Cells respond to MFHR in different ways. A) MFHR images show 
representative images from each of the three classes of response to MFHR. Class I 
images have a bright RN. Class II images have a pale RN. Class III images do not 
have a clearly defined RN and appear disintegrated. B) Histogram shows example 
of proportion of MFHR images in each class for 3T3 and HeLa cell lines. C) Left: 
Histogram shows average halo radius for 3T3 cell line when using all cells or just 
class I or class II. Right: Frequency distribution of halo radius measurements. D) 
Histogram shows average halo radius measurements from 6 cell lines (A-F) using 
either all cells or just class I cells showing the impact that class II cells can have on 
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Figure 3.12: Stability measurements for MFHR halos. A) Images show MFHR 
images taken over a 1 min timecourse of exposure to > 590 nm light, showing RN 
and outer threshold analysis images. B) Graph shows halo radius calculated from 
the cell shown in A. After 40 s no measurement can be taken and the image is said 
to have failed the HIM. C) Example stability of halo radius measurements from 
individual cells of two cell lines. D) Average of the stability data from C, presented 
as percentage of cells which have a measurable halo at each timepoint with SEM. 
Only class I cells were used for this analysis. E) Alternative presentation of data in 
D), a conversion factor was applied to the data derived from the percentage of cells 
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Figure 3.13: MFHR results do not vary significantly by cell culture media or density. 
A) Average halo radius for 3T3 cells grown in various cell culture media as 
indicated. B) Class distribution of 3T3 MFHR images from cells in A. C) 
Representative bright field images of cells in A and B. D) Average halo radius for 
3T3 cells plated at various density as given by percentage of confluence. E) Class 
distribution of 3T3 MFHR images from cells in D. F) Representative bright field 
images of cells in D and E. For all conditions measurements were calculated from 
two coverslips (n=2), except RPMI for which data was collected from two coverslips 
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 One-Way ANOVA 
MSCh1-5 F(4, 853) = 30.35, p <0.0001 
MSCh1, 3, 5 F(2, 567) = 62.34, p = 0.17 
MSCh2-4 F(2, 442) = 1.148, p = 0.32 
 One-Way ANOVA 
MSCh1 F(3, 331) = 17.84, p < 0.0001 
MSCh2 F(3, 154) = 1.684, p = 0.17 
MSCh3 F(3, 153) = 2.586, p = 0.055 
MSCh4 F(3, 126) = 3.410, p = 0.020 
MSCh5 F(3, 74) = 0.7584, p = 0.52 
Figure 3.14 ANOVA results for example data set (MSC, chapter 4). A) Histogram 
showing average halo radius for 5 different MSC lines with indicated p values from 
Student’s t-test. B) One-Way ANOVA results presented from replicates of each cell 
line indicating the level of variability within each cell line (top) and between 
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Figure 3.15: Method for MFHR Matrix Attachment Regions of DNA (MARs). A) 
Schematic showing steps of MFHR halo and MFHR derived MAR protocols. B) 
MFHR images from standard MFHR protocol (MFHR halo) and performed in 
solution using scraped cells. C) Images from MFHR MAR protocol as B +/- DNase I 
treatment in DNase buffer (37°C, 30 mins). D) Agarose gel showing impact of 
DNase I from Roche (R) or Epicentre (E) on RNA samples prepared by Trizol 
extraction. E) Agarose gel showing MFHR MAR samples (+ DNase I at the indicated 
concentrations) processed until gel purification. F) As E except changing proteinase 
K treatment and omitting RNase I treatment. * indicates 15 min, 95 °C pretreatment. 
G) Agarose gel showing MFHR MAR samples processed until gel purification using 
the conditions shown. H) MFHR MAR samples A and B showing gel slice cut from 
100 bp to 5 kbp (red boxes). I) MFHR MAR DNA fragments from H visualised using 
2100 Bioanalyzer (Agilent). Graphs show fluorescence units x base pairs.  
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Figure 3.16: Example alignment of MARs to a small region of mouse chromosome 
1. MARs are shown as vertical red bars. Only MARs with a mean coverage of reads 
of >5 are shown. Cy refer to cyclin samples. Q and Qu refer to quiescent samples. 
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Figure 4.1: Chromatin loops are remodelled during entry to quiescence. A) 
Representative cycling and quiescent MFHR images with threshold analysis images 
from HIM (below). DNA is stained with ethidium bromide (white), and the area 
occupied by the nuclear matrix is visualised with EGFP-CIZ1 C-term274 (green) 
(Ainscough et al. 2007). Scale bar is 10 µm throughout. B) Confirmation of 
quiescence by propidium iodide incorporation and Flow cytometry analysis. 
Example images (right) show cycling and quiescent populations of cells, 
counterstained with Hoechst 33258 (blue). C) Frequency distribution of 3T3 halo 
radius shows quiescent cells have smaller chromatin loop size. Data are derived 
from cells whose halo boundaries fall within the range quantifiable with HIM 
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Figure 4.2: Chromatin loops size recovers during exit from quiescence. A) The 
timing of re-entry to cell cycle for 3T3 cells is confirmed by BrdU incorporation (red 
in inset image). DNA counterstained with Hoescht 33258 (blue). Scale bar is 10 µm. 
The timepoints for the majority of MFHR analysis are illustrated by arrows. B) 
Detailed investigation of recovery shows halo size returns to cycling size by 12 
hours. Results are expressed as rolling average of 3 timepoints, error bars are 
SEM. C) Recovery of halo size for cells released into fresh media with or without 
serum Data presented here, and all further size measurements, are derived from > 
100 halos per condition from > 4 coverslips, error bars are SEM. p values from 
Student’s T-test. * ! 0.05, ** ! 0.005, *** ! 0.0005. D) Recovery of halo size for cells 
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Figure 4.3: Chromatin loop size recovery does not depend on cyclin E. A) Average 
halo size measurements for cyclin E1-/- E2-/- MEFs are similar to control MEFs, in 
cycling, quiescent and G1 cells. Data collected as 4.2 C. B) Confirmation of 
absence of cyclin E1-/- E2-/- cells by RT-PCR (primers specified in chapter 2). C) 
Confirmation of absence of cyclin E at protein level by western blot (antibodies 
specified in chapter 2, ab7959). D) Representative re-entry to the cell cycle, 
monitored by BrdU incorporation.  
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Figure 4.4: Transformation and increased severity of cancer correlates with 
increased halo size. A) Halo size (left) and class distribution (right) measurements 
for a panel of non-cancer cell lines. BJ and MSCh1 immortilised by hTERT, MEF by 
DNp53, MCF10A and 3T3 spontaneously, ARPE19 and NHU not immortilised. Size 
data collected as 4.2 C and 4.5 B except BJ, 2 coverslips. ND, not determined. B) 
Schematic of the relationship between MSCs with increasing number of oncogenic 
hits (adapted from Funes et al. 2007). C) Left: Example MFHR and threshold 
analysis pictures for MSCh1 and MSCh5. Average halo size measurements for 
MSC lines with 1-5 transforming hits as indicated. Colours correspond to those 
used previously (Funes et al 2007). Data collected as 4.2 C. D) Mean halo radius 
determined for breast epithelial cell lines, derived from normal tissue (MCF10A) or 
tumours (MCF7 and MDA-MB-231). Data collected as 4.2 C except for MDA-
MB-231, 2 coverslips. E) Mean halo radius for bladder epithelial cancer lines 
(RT112, RT4 and EJ). Data collected as 4.2 C.  
 
Amanda Collier (summer student) helped with MFHR of RT4, RT112, EJ and MCF7. 
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Class I and II cells only 






Figure 4.5 Transformation destabilises chromatin loops. A) Example halo images for 
different class response to MFHR with threshold analysis images. Class I have a 
bright RN, class II a pale RN and class III have an  indistinct/disintegrated RN. B) 
Class distribution shown for MSC lines. Data presented here, and all further class 
distributions, are derived from > 100 halos per condition from > 4 coverslips, error 
bars are SEM. p values from Student’s T-test. * ! 0.05, ** ! 0.005, *** ! 0.0005. 
Shading reflects the proportion of cells in classes I-III as indicated. C) Images show 
decay of a halo over time, with corresponding HIM threshold analysis images. D) 
Stability measurements over time of class II MSCh1 (n=15) and MSCh5 (n=30) 
cells. Note that 4 MSCh1 cells failed by 10s, compared to 18 MSCh5 cells. E) 
Results show proportion of all cells (left) or class II cells only (right) whose halos fall 
within threshold parameter of HIM at the indicated timepoint, with SEM. Data 
presented, and for all further stability measurements, are derived from 32 halos per 
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Figure 4.6: Increased severity of cancer cells correlates with destabilisation of 
chromatin loops. A) Class distribution of halos from breast epithelial cell lines. Data 
collected as 4.5 B, except MDA-MB-231, 2 coverslips . Shading reflects the 
proportion of cells in classes I-III as indicated. B) Class distribution of halos from 
bladder epithelial cancer cell lines. Data collected as 4.5 B. Shading reflects the 
proportion of cells in classes I-III as indicated. NS, not significant. C) Stability 
measurements for bladder epithelial cancer cell lines. Data collected as 4.5 E.  
 
Amanda Collier (summer student) helped with MFHR of RT4, RT112, EJ and MCF7. 
Cancer severity 
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Figure 4.7: Transformation with E6 correlates with increased CIZ1. A) CIZ1 is 
retained as discrete NM-associated foci after MFHR (fixation protocol, see materials 
and methods). Left: CIZ1 protein detected with 1793 (white). Right: DNA stained 
with DAPI (white). Centre: Merged image, CIZ1 in white, DNA in magenta. B) CIZ1 
protein (detected with NB100-74623) in whole cell extracts from MSCh1 to MSCh5. 
Actin is used as loading control. Histogram (right) shows quantification of CIZ1 
doublet relative to actin.  
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Figure 4.8: Schematics showing chromatin remodelling events. A) Schematic shows 
options for chromatin loop remodelling event as cells enter quiescence. Grey box 
indicates loop remodelling event. B) Schematic shows events during G1M. ODP 
origin decision point, R, restriction point, S, S-phase, TDP, timing decision point. C) 
Schematic shows events during G1Q. Grey dashed arrows indicate roles for CIZ1. 
Not shown to scale. 
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Figure 4.9: Model of how CIZ1 may interact with chromatin loops. A) Options shown 
for the role of normal CIZ1 and B) how altered CIZ1 expression in cancer cells may 
affect chromatin loop maintenance, choice or stability. 
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Figure 5.1: CIZ1-/- TTFs proliferate slower than wild type cells. A) Western blot of 
total cell lysate from TTFs (+/+ 101 and -/- 1017), detected with antibody 1793. 
Actin is shown as loading control. B) Representative immunofluorescence of total 
CIZ1 protein in CIZ1+/+ and CIZ1-/- TTFs detected with anti-CIZ1 antibody 1793. 
DNA is counterstained with Hoechst 33258, scale bar is 10 microns. C) Frequency 
distribution graph shows little difference in nuclear area between +/+ and -/- cells as 
determined by area of Hoescht 33258 staining. D) Proliferation of passage 2 TTFs 
+/+ (126, 133) and -/- (1017, 1018), over 6 days, expressed as fold increase in cell 
number relative to day 1. Data are average, ± SEM. E) Mean relative doubling time 
for TTFs +/+ (101, 126, 133) and -/- (1017, 1018) at passage 2, 3 and 4. F) By 
passage 5 proliferation is negligible. G) Histogram and representative image 
showing proportion of cells expressing p53. Data are average ± SEM. Positive 
control is a spontaneously immortilised cell line from CIZ1-/- foci. H) Histogram and 
representative images showing cells in apoptosis, determined by TUNEL assay. 
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Figure 5.2: CIZ1-/- populations contain increased numbers of G1 cells and less S-
phase cells. A) Histogram shows percentage of TTFs CIZ1+/+ (97, 101, 126) and 
CIZ1-/- (1016, 1017, 1018) cells (passage 3-4) that engaged in DNA synthesis 
during a 30 min pulse with EdU (S-phase). Data are average from multiple 
experiments ± SEM, ** p< 0.005. B) Representative flow cytometry profile for 
propidium iodide stained TTFs +/+ (133) and -/- (1018). The proportion of cells in 
G1, S and G2 were determined using the boundaries indicated by dotted lines.  
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Figure 5.3: S-phase is unaffected in CIZ1-/- cells. A) Stacked histogram showing S-
phase staining patterns in TTFs. Cells received an EdU pulse of 30 mins followed 
by a chase period of 4 hours prior to a BrdU pulse of 30 mins. EdU (pulse 1) pattern 
is depicted on the x-axis. BrdU (pulse 2) pattern is depicted in grey scale, see key. 
Representative images are shown of major BrdU (pulse 2) patterns for each EdU 
(pulse 1) pattern observed. EdU, red; BrdU, green; DNA, blue. Merged images 
show no co-staining indicating no incorporation in the same place. B) Histogram 
shows frequency of each S-phase pattern in TTF CIZ1+/+ (101, 126) and CIZ1-/- 
(1017, 1018) at passage 4. C) Box and whisker plot showing fluorescence intensity 
of EdU incorporation (30 min pulse) for each S-phase pattern for +/+ and -/- TTFs. 
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Figure 5.4: Cyclin D and E expression is prolonged and cyclin A expression reduced 
in the absence of CIZ1. A) Histograms with representative images (below) show 
percentage of CIZ1+/+ (97, 101, 126) and CIZ1-/- (1016, 1017, 1018) cells 
(passage 3-4) within a cycling population that express the indicated cyclins. Filled 
bar shows the indicated cyclin, open box shows the percentage that also 
incorporated EdU. EdU data for cyclin D2 and cyclin E1 are from the same 
experiment, cyclin A2 from a separate experiment. Cyclin data are average ± SEM. 
** p< 0.005. B) Mean fluorescence intensity (left) and intensity distribution (right) for 
all TTFs within a cycling population stained for total cyclin D2, expressed in arbitrary 
units. C) As B except S-phase population is shown (determined by EdU 
incorporation after 30 min pulse). D) As B except for cyclin E1. E) As C except for 
cyclin E1.  
A 
DNA  Cyclin E1   EdU DNA  Cyclin D2   EdU 






























































































































































































































































41%! ';%('7%! +%;%+! #6! F)F+/,! IA! /,! 41%! F%++$! 41'4! %J>(%$$! /4O! G'$! '3,#(&'++)! 1/71! /,!
-RSCQTQ! F%++$! K6/7! \M\LM! 01/$! G'$! 4(2%! 6#(! %'F1! F+'$$! #6! NQ>1'$%! >'44%(,! K3)! P5:!
$4'/,/,7LO!G/41! F)F+/,! I! +%;%+$! 1/71%(! /,! %'F1! F+'$$O!G/41! 3%4G%%,! DA!r! ',5! ^D!r!




\M\! IO! ?O! PLO! >'/,4/,7! '! ;%()! F#,$/$4%,4! >/F42(%! #6! F%++! F)F+%! >(#7(%$$/#,! /,! 41%!
>(%$%,F%! #6! 2,2$2'++)! 1/71! +%;%+$! #6! F)F+/,! IM! H#4'3+)O! G1%,! $#+23+%! F)F+/,! I!G'$!





#6! F)F+/,! I! /,! #(5%(! 4#! /,/4/'4%! 9HI! (%>+/F'4/#,! 41(#271#24! 41%! NQ>1'$%! >(#7('&M!
8(%;/#2$! 5'4'! /,5/F'4%5! 41'4! -RSC! /$! (%W2/(%5! 6#(! 5%+/;%()! #6! F)F+/,! I! 4#! /,$#+23+%!
$4(2F42(%$!K-#>%+',5!%4!'+MO!ABCBLO!1#G%;%(O! /,!-RSCQTQ!F%++$!41%!5%4%(7%,4Q(%$/$4',4!
F)F+/,!I!G'$!,#4!(%52F%5M!01%(%6#(%O! 41/$!$277%$4$!41'4!41%!4#4'+! +%;%+!#6!F)F+/,!I! /$!
/,F(%'$%5! 4#! 6'F/+/4'4/,7! 3/,5/,7! #6! F)F+/,! I! 4#! '>>(#>(/'4%! K',5! >#$$/3+)!
/,'>>(#>(/'4%L!$/4%$!/,!'!$4#/F1/#&%4(/F!&',,%(!/,!41%!'3$%,F%!#6!41%!(%F(2/4%(!-RSCM!
R4!$1#2+5!3%!F#,$/5%(%5!G1%41%(!41%!5%4%(7%,4Q(%$/$4',4!>##+!#6!F)F+/,!I!/,!-RSCQTQ!
F%++$! /$! /,'F4/;%O! >#$$/3+)! 52%! 4#! >AC-R8C! /,1/3/4/#,M! *#G%;%(O! %;/5%,F%! $277%$4/,7!





Figure 5.5: CIZ1-/- cells execute all stages of S-phase with elevated levels of cyclin 
A. A) Representative images for CIZ1+/+ and CIZ1-/- TTFs showing EdU (red) 
incorporated into newly synthesized DNA during a 30 minute pulse immediately 
prior to isolation. Cyclin A shown in green. EdU was imaged at low and high 
exposure time. A combination of intensity and pattern was used to classify cells as 
initiating, early, mid, and late S-phase. Scale bar is 10 microns. B) Average total 
cyclin A intensity was elevated at all stages of S-phase in CIZ1 -/- cells (black bars). 
n= 12-68 nuclei per class, data are average ± SEM, TTF used were +/+ 101, 126 
and -/- 1017, 1018, at passage 4. C) Total cyclin A and detergent-resistant (Det.R)
cyclin A in S-phase cells (all classes), with derived soluble pool (Sol.) intensity. 
Right: Total level of cyclin A determined by densitometry from Western blot. Actin 
was used as a loading control. D) Frequency distribution for cyclin A intensity, 
showing total cyclin A (left) and the detergent-resistant fraction (right) from the 
whole population. E) As D except categorised by S-phase stage, showing elevated 
total but not immobilised cyclin A in CIZ1-/- cells at all stages of S-phase.  
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Figure 5.6: CIZ1-/- cells show little change in investigated pre-RC components. A) 
Histogram showing percentage of cycling TTFs (+/+ 101, -/- 1018) expressing 
ORC1 with representative image, DNA in blue, ORC1 in red, scale bar 10 µm. * = 
p<0.05. B) Frequency distribution showing fluorescence intensity of ORC1 in the 
positive population from A, expressed in arbitrary units. C) As A except for CDC6, 
shown in red. D) As A except for MCM2 total and detergent resistant protein. MCM2 
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Figure 5.7: Schematic representation depicting dysregulation of cyclin D2, E1 and 
A2 expression in TTFs in the presence and absence of CIZ1. The proportion of 
CIZ1+/+ cells with cyclins D2, E1 or A2, and those that co-stain for EdU fits well with 
the established profile for cyclin expression and cell cycle progression in normal 
cells. However, the data for CIZ1-/- cells cannot be fit to the same model, even 
when 2.5-fold longer cycling time is taken into account. The model was constructed 
as follows; 1. Cell cycle length reflects the calculated 2.5 fold increase in doubling 
time. 2. G1 and G2 proportion determined from flow data. 3. S-phase proportion is 
determined by EdU incorporation. 4. Time of cyclin expression (width of peak) is 
determined from immunofluorescence staining data. 5. Overlap of cyclin expression 
with S-phase determined from immunofluorescence co-staining with EdU. 6. Height 
of cyclin A peak reflects increased expression level. This model assumes that all 
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Figure 5.8: Absence of CIZ1 results in increased p21CIP1 immobilisation. A) 
Histograms and representative images show proportion of cells expressing total and 
detergent resistant p21CIP1 in passage 3-4 cycling populations of TTFs CIZ1+/+ 
(101, 126) and CIZ1-/- (1016, 1017, 1018). Data are average ± SEM.*** = 
p<0.0005. p21CIP1 shown in green, DNA shown in blue. Scale bar is 10 microns. B) 
As A, except S-phase population is shown (identified by EdU incorporation). C) 
Mean fluorescence intensity (left) and intensity distribution (right) for all TTFs within 
a cycling population stained for total p21CIP1, expressed in arbitrary units. Cells as in 
A. D) As C except S-phase population is shown. E) Histogram shows percentage of 
cells with detergent resistant p21CIP1 which co-stain for cyclin D2. Representative 
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Figure 5.9: Absence of CIZ1 results in increased p27KIP1 expression. A) Histograms 
and representative images show proportion of cells expressing total p27KIP1 in 
passage 3-4 cycling populations of TTFs CIZ1+/+ (97, 101, 126) and CIZ1-/- (1016, 
1017, 1018). Data are average ± SEM.*** = p<0.0005. p27KIP1 shown in green, DNA 
shown in blue. Scale bar is 10 microns. B) As A, except S-phase population is 
shown (identified by EdU incorporation). C) Histogram (left) and frequency 
distribution (right) show fluorescence intensity of p27KIP1 for total cell population (as 
A). Data are average ± SEM. D) As C except S-phase population is shown, 
separated by class (5-12 cells) ** = p<0.005. Representative images (above), EdU 
shown in red, p27KIP1 shown in green. 
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Figure 5.10: CIZ1-/- cells fail to form contact inhibited monolayers. A) Foci incidence 
per 4.5x10(5) cells for TTFs CIZ1+/+ (101 and 126) and CIZ1-/- (1017 and 1018) 
cells, plated at passage 4, and visualised by staining with crystal violet after 21 
days. Data are average from triplicate ± SD. Images show representative plates, 
scale bar is 1cm. Similar results were obtained with all TTF cells. B) As in A, but for 
PEFs (passage 3-4). C) Representative images show replicative quiescence in 
monolayers cells in both CIZ1 +/+ and CIZ1 -/- cells after a 16 hour pulse with EdU. 
Right: 15% of -/- cells within focal outgrowths were in S-phase. TTFs used were +/+ 
(126, 133), -/- (1017, 1018). D) Histogram and representative image show 
expression of MCM2 in a proportion of foci cells. Cells as in C.  E) Bright field image 
of the edge of a growing colony of -/- TTF cells showing invasion of the surrounding 
monolayer. Scale bar is 20 µm.  
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Figure 5.11: Contact inhibited but not cycling CIZ1-/- cells show activated DDR. A) 
Histogram and representative images show TTFs with !H2AX in large subnuclear 
foci. TTFs used were CIZ1+/+ (126, 133), CIZ1-/- (1017, 1018). B) Histogram 
shows proportion of TTFs (+/+ 101, -/- 1017) expressing detergent resistant pChk1. 
C) Histogram shows proportion of TTFs (as in B) expressing detergent resistant 
pATM. For all DDR markers, cells with " 3 large foci were scored positive. Data are 
average ± SEM. *** = p<0.0005. D) Histograms shows percentage of cycling, 
monolayer and foci TTFs expressing p53 (left) or positive for TUNEL (right)
Representative images fro positive controls shown. E) Histograms show percentage 
of cycling TTF populations expressing !H2AX, pATM, pChk1 and phospho-(Serine/
threonine) ATM/ATR substrate motif as indicated. Representative images are 
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Figure 5.12 (Previous page): Schematic showing possible mechanisms for why 
absence of CIZ1 causes activation of DDR. DNA shown in blue, NM as grey mesh, 
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Figure 6.1: Common representations of chromatin loops. A) Refined model 
illustrating variable chromatin loop sizes, and complex S/MAR usage, including 
function-related alternative potential S/MARs. B) Alternative representation of 
chromatin loops showing replication origin clustering within a DNA replication 
factory, with no representation of NM attachments. Our preferred model combines 
NM attachment and factory formation.  
 
Previously published in (Wilson and Coverley, 2013). Designed by R. Wilson, drawn 
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Figure 6.2: Possible relationships between DNA replication and the nuclear matrix. 
Our preferred model showing attachment to the NM via non-origin S/MARs, and 
recruitment of DNA replication origins at G1/S-phase with possible impact on loop 
size.  
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Figure 6.3: Schematic combining data on chromatin loops and the nuclear matrix for 
different cell types. DNA represented in black, nuclear periphery and NM in grey. 
Data presented here show increased chromatin loop size and reduced stability in 
cancer (section 4.4.5-7), altered NM is discussed in section 1.5. Increase in 
chromatin loop size during differentiation is discussed in section 7.3.3, altered NM 
discussed in section 1.4.10. Data presented here show reduced chromatin loop size 
in quiescent cells (section 4.4.1), also discussed, along with differences in NM 
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Figure 6.4: Events during cell cycle re-entry in which CIZ1 is believed to play a part. 
Data from (Copeland et al., 2010; Coverley et al., 2005; Knight, L., personal 
communication) and from CIZ1-/- cells investigated here. Events are depicted in 
relation to R, presumed ODP and S.  
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Appendix A: Chromatin loops are smaller in quiescent cells and increase as cells 
return to the cell cycle, in a mechanism dependent on CIZ1. A) Visual MFHR Halo 
radius measurements from asynchronous cycling populations (Cy.) or from 
synchronised populations at the stated cell cycle phase. Data are average from >8 
nuclei from "2 technical replicates, error bars are SEM. B) Halo measurements as 
in A except taken after transfection of quiescent cells with Ciz1 siRNA. Controls are 
shown in Copeland et al 2010, figure 5.  
 
Data generated in the Coverley lab group prior to this PhD project and presented 
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Appendix B: Generation and confirmation of CIZ1-/- mice. A) Map showing cassette 
which is inserted after exon 1. B) Q RT-PCR data showing " 99 % reduction in CIZ1 
mRNA expression in CIZ1-/- TTFs. 
 
Data kindly provided by and presented with permission from Justin Ainscough, 
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Figure C1: Validation of cyclin E siRNA. Cells were transfected with the indicated 
cyclin E siRNAs, ciz4 (Coverley et al., 2005) or as a mock transfection. Transcript 
analysis shows effect on A) cyclin E1 or B) cyclin E2 expression. qRT-PCR data 
were normalised to actin and expressed relative to mock treated control. Data are 
average of triplicate wells, error bars are SEM. The siRNA used in later 
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Figure C2: The E4 epitope is NM bound in cycling but not quiescent 3T3 cells. A) 
E4 foci remain in cycling cells treated with detergent, high salt or high salt and 
DNase. E4 epitope shown in green, DNA counterstained with Hoechst 33258 (blue). 
82 % (± 7.8 SEM) of cycling 3T3 cells retain E4 foci after DNase treatment. B) E4 
foci in quiescent populations resist detergent and high salt treatment but not 
DNase. Staining as above. 7 % (± 3.3 SEM) of quiescent 3T3 cells retain DNase 
resistant  E4 foci.  Scale bar is 10 µm. 
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Figure C3: The E4 epitope rebinds to the NM by one hour after release back into 
the cell cycle. A) Top: E4 foci resist high salt treatment in quiescent populations and 
cells released back into the cell cycle at the indicated time points. Staining as figure 
C2. Scale bar is 10 µm. Lower: E4 foci do not resist DNase treatment in quiescent 
cells but become DNase resistant when cells are released back into the cell cycle at 
the indicated timepoints. B) Histogram shows percentage of cells retaining DNase 
resistant E4 foci at indicated timepoints. C) Graph shows percentage of cells in S-
phase at indicated timepoints from representative release (black) and percentage 
retaining NM bound E4 epitope (green). S-phase is determined by BrdU 
incorporation. Inset: representative images shows BrdU staining. BrdU shown in 
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Figure C5: Inhibition of proteasome dependent proteolysis or cdks does not affect 
E4 epitope recruitment to the NM. A) E4 epitope becomes resistant to DNase by 1 
hour after release in the presence of vehicle, MG132, Roscovitin or Olomucine. 
Staining as figure C2. Scale bar is 10 µm. B) Histogram shows no difference 
between cells released into media containing vehicle or MG132 in terms of 
percentage of cells with DNase resistant E4 foci.  
1hr:  MG132 
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Figure C4 (previous page): The recruitment of E4 epitope to the NM is independent 
of serum. A) Representative images show the E4 epitope becomes resistant to 
DNase by 1 hour after release whether cells are released into media containing 10 
% serum or media containing 0 % serum. Staining as figure C2. Scale bar is 10 µm. 
B) Histogram shows no difference between cells released into media with or without 
serum in terms of the percentage of cells with DNase resistant E4 epitope at 
indicated timepoints. C) Images show E4 does not become recruited to DNase 
resistant structures if quiescent cells are treated for 1 hour with media containing 
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Figure C6: Depletion of CIZ1 during release from quiescence does not affect E4 
epitope recruitment to the NM by 1 hour. A) During release from quiescence, 3T3 
cells were treated with no siRNA (electroporation only – mock), scrambled CIZ1 
siRNA or CIZ1 siRNA.  Images show E4 foci become resistant to DNase by 1 hour 
irrespective of siRNA treatment. E4 shown in green, CIZ1 shown in red, DNA 
counterstained with Hoechst 33258 (blue). B) Scale bar is 10 µm. Histogram shows 





































Figure C7: Depletion of CIZ1 in cycling cells does not affect E4 epitope recruitment 
to the NM. A) Cycling 3T3 cells were treated with no siRNA (electroporation only – 
mock), scrambled CIZ1 siRNA or CIZ1 siRNA.  Images show E4 foci remain 
resistant to DNase irrespective of siRNA treatment. Staining as figure C6. Scale bar 
is 10 µm. B) Histogram shows percentage of cells with DNase resistant E4 foci after 
indicated siRNA treatment.  
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Figure C8 (previous page): The !-cyclin E antibody E4 recognises an epitope found 
in cyclin E1-/- E2-/- cells. A) Images show E4 staining in WT MEF and cyclin E1-/- 
E2-/- cells with indicated E4 antibody lots or in the absence of primary antibody (no 
primary) in which only the secondary antibody was used. Staining as figure C2. 
Scale bar is 10 µm. B) Images show E4 staining using indicated concentrations of 
antibody. In all other immunofluorescence images a concentration of 1:100 (2µg/ml) 
was used. C) Western blot showing absence of 50 kDa doublet from cyclin E1-/- 
E2-/- sample using ab7959 antibody. Samples are total protein extracts from 
indicated cells. Histone H3 is shown as a loading control. D) Images show an 
absence of significant co-localisation between either E4 and CIZ1 (staining as 
figure 6.5) or E4 and CDK2 (E4 shown in green, Cdk2 shown in red, DNA 
counterstained with Hoechst 33258, shown in blue) for DNase treated cells. Scale 
bar is 10 µm.  
A 
Figure C9: Comparison of !-cyclin E antibodies. A) Western blot strips show long 
exposures of band pattern from indicated antibodies or secondary antibody only 
controls (2º). Note absence of E4 specific 50kDa band unlike 50kDa doublet 
recognised by Abcam ab7959 (ab.) or Upstate 07-687 (up.) indicated by black 
arrow. Grey arrows mark E4 specific bands. Strips are total protein extracts from 
3T3 cells. B) Western blot shows absence of 50kDa cyclin E band in cyclin E1-/- 
E2-/- cells and that cyclin E in WT MEF cells is detergent resistant but extracted 
with 0.5 M NaCl (W). For lane descriptions see materials and methods section 
2.5.2. All lane contain cellular equivalents except detergent supernatant (Det. SN) 
which is two fold less. Histone H3 is shown as control for DNase extraction, 
remaining in the pellet without DNase extraction (mock) but extracted by DNase 
and present in DNase supernatant. C) Western blot shows absence of 50kDa cyclin 
E band from 3T3 cells treated with cyclin E siRNA (E siRNA) compared to cells 
treated with no siRNA, electroporation only (M.) or with scrambled cyclin E siRNA 
(S.). Samples are total protein extracts. Histone H3 is shown as loading control. 
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Abstract CIZ1 promotes cyclin-dependent initiation of DNA replication via its N-terminal 
replication domain (RD). A nuclear matrix anchor domain (AD) immobilizes CIZ1 on the 
nuclear matrix in normal, differentiated cells, but neither AD nor recruitment to the nuclear 
matrix are essential for CIZ1 to promote DNA replication. We show that, like its 
interaction partner cyclin E, CIZ1 transitions from the soluble phase to the nuclear matrix 
during differentiation of murine embryonic stem cells, and that this coincides with complex 
changes in isoform expression. In cell-based assays recombinant AD interferes with 
attachment of endogenous CIZ1 to the nuclear matrix, revealing a dominant negative 
function that also impacts on nuclear matrix-recruitment of CDC6, a key component of the 
pre-replication complex. Notably, expression of CIZ1 is elevated in a panel of cancer cell 
lines, but RD and AD are uncoupled giving rise to excess RD protein that is not attached 
to the nuclear matrix. We suggest that release of CIZ1 RD from the nuclear matrix can be 
achieved in several ways, including the dominant negative action of AD and expression of 
isoforms that lack AD. Release may function to relax the spatial constraints normally 
imposed on initiation of DNA replication in the differentiated nucleus.  
 $




Introduction  Duplication of the mammalian genome is initiated at thousands of DNA 
replication origins, whose selection and activation is coordinated with changing patterns 
of gene expression. Spatial and temporal regulation of DNA replication is underpinned by 
a dynamic, insoluble protein and RNA-rich framework, referred to as the nuclear matrix 
(NM) 1,2. The NM has been implicated in the spatial organisation of DNA replication for 
nearly forty years 3-5, though analysis in a diverse array of cell types and by multiple 
methods has led to the emergence of a somewhat confusing picture (reviewed in 6. 
However, it is now understood that components of the pre-replication complex (pre-RC) 
including CDC6 and ORC1 7,8 and also virally-encoded DNA replication factors 9 can 
undergo transient, functional NM-association. Similarly, activities that limit initiation of 
DNA replication to S phase of the cell cycle have also been reported to function in 
association with the NM 10, while we showed directly that cyclin E, a regulator of pre-RC 
assembly 11,12, is stably recruited to the NM in normal differentiated somatic cells 13. 
Moreover, using three independent experimental models of differentiation, we identified a 
solubility transition that appears to reflect a change in the structural organisation of DNA 
replication during cell specification. In undifferentiated, multi-potent cell types cyclin E is 
not immobilized by association with the NM, but becomes recruited in differentiated cells 
that have established an identity and associated transcriptional program 13. This shift 
implies that initiation of DNA replication becomes spatially constrained as template usage 
is defined, suggesting that the NM may offer a platform on which pattern is established or 
a framework for its maintenance. Notably, cyclin E was not immobilized on the NM in a 
panel of cancer cell lines, suggesting that there are fundamental differences between 
‘normal’ and cancer cells with respect to the spatial organisation of DNA replication. This 
also raises the possibility that the impact of deregulation of cyclin E on genome stability 
14, and pre-RC assembly 15, may in part arise by overriding the organisation imposed by 
attachment to the NM.  
 
Several proteins have been proposed as potential mediators between the NM and the 
pre-RC or other regulators of initiation, including MCM2 interacting protein AKAP95 16, 
and Cip1-interacting zinc-finger protein 1 (CIZ1) 17,18. Here we focus on the CIZ1 protein 
and show that it is not only a NM linker 19, but that variants of CIZ1 have the capacity to 
modulate the linkage, identifying a mechanism by which changes in anchorage, and 
potentially therefore in DNA replication pattern, may be effected. CIZ1 appears to function 
as a platform for cyclin exchange in late G1 phase and has been shown to interact 
directly with cyclin E and cyclin A through discrete RXL cyclin binding motifs which are 
essential for its ability to promote DNA replication in vitro 20. These are encoded within 
exons 3-9, excluding exon 4 21, which together make up the minimal N-terminal DNA 
replication domain (RD). Although normally spatially constrained via its C-terminal anchor 
domain (AD), encoded within exons 13-17 19, immobilization on the NM is not essential 




for the cyclin-dependent function of CIZ1 in initiation (13). Thus, CIZ1 is made up of at 
least two independent and separable functional domains, RD which promotes initation 
and AD which spatially constrains this activity. Importanatly, we find that RD and AD are 
not always expressed together and that in the panel of cancer cell lines we tested there 
exists excess unconstrained RD protein that is not immobilized on the NM. 
 
Materials and methods 
Cell culture and transfection:  Cell lines were from ATCC or JCRB, and were cultured as 
recommended for less than 6 months from receipt, except HeLa cells and NIH3T3 cells 
which were obtained from R. Laskey, and T24/EJ, RT4 and RT112 cells which were 
characterised previously 22. All experiments were performed with sub-confluent cells in 
the exponential phase of growth. NIH3T3 cells were grown as previously described 11, 
and transfected with GFP-CIZ1 or GFP-AD (also known as Cterm275 19, using Amaxa 
nucleofector kit R. ES cells were cultured and differentiated as described previously 13. 
 
Sub-cellular fractionation: Detergent-soluble and DNase1 soluble proteins were extracted 
from cells essentially as described 13. Typically, cells on coverslips were rinsed with cold 
PBS then fixed with fresh 4% paraformaldehyde (‘unextracted’), or washed with cold CSK 
buffer (10mM Pipes/KOH pH 6.8, 100mM NaCl, 1mM EGTA, 300mM sucrose, 1mM DTT, 
0.1% TX100, with protease inhibitor cocktail), then fixed with 4% paraformaldehyde to 
generate ‘detergent-treated’ cells. For ‘DNase treated’ cells, coverslips were incubated in 
DNase1 buffer (10mM Tris [pH 7.6], 2.5mM MgCl2, 0.5mM CaCl2), for 20 min at 25 °C, as 
recommended by supplier (Roche) after CSK treatment and prior to fixation. For western 
blot analysis, fractionation was carried out as described 13, to generate a total cell lysate 
(T), a detergent pellet (Det. P) and a detergent-soluble supernatant (Det. SN) fraction. By 
further washing of the detergent pellet with CSK containing 0.5M NaCl, a salt wash (or 
‘w’) fraction is generated, and further treatment of the pellet with DNase1, yields DNase1 
P (nuclear matrix and nuclear matrix-bound proteins) and DNase1 SN (chromatin and 
chromatin bound proteins). Control incubation of Det. P in the absence of enzyme yields 
mock P and mock SN.   
 
Immuno-detection: CIZ1-RD was detected with anti-CIZ1 polyclonal antibody 1793 raised 
against recombinant Nterm442 17,19-21 and CIZ1-AD with polyclonal antibody 2C raised 
against CIZ1 AD sequences and affinity purified using peptide 
DEDEEEIEVEEELCKQVRSRDISR (Covalab). DNA was counterstained with Hoechst 
33258 (Sigma). CDC6 was detected with sc9964 clone 180.2 (Santa Cruz), ORC4 with 
ab9641 (abcam), MCM2 with 610700 clone 46/BM28 (BD Transduction Laboratories), 
and histone H3 with ab179 (Abcam).  
 




Imaging: Images were collected using a Zeiss Axiovert 200 M fitted with a 63x oil 
immersion objective, and Openlab image acquisition software, using identical exposure 
parameters within each experiment. Where images were digitally enhanced to remove 
background fluorescence or increase brightness using Adobe Photoshop, identical 
manipulations were applied within each experiment, so that the intensity of staining 
before and after extraction, and with and without transfection is accurately represented. 
Moreover, constant parameters were used to image different cell lines so that 
fluorescence intensity represents relative levels of CIZ1. No conclusions should be drawn 
about relative levels of CIZ1 RD and CIZ1 AD protein, due to possible differences in 
antibody affinities. 
 
Quantitative RT-PCR:  RNA from cell lines was isolated with Trizol (Invitrogen) and cDNA 
synthesized using Superscript III (Invitrogen) and random hexamers (Promega). Primers 
and probes used to quantitate CIZ1 RD and AD were described previously 23. These were 
primers 13/14 with a probe in exon 7 (RD) and 6/7 with a probe in exon 16 (AD). Relative 
expression was calculated using the comparative Ct method (2-!!Ct). Results were 
normalised to actin and expressed relative to normal cells as indicated. 
 
  




Results  Analysis of CIZ1 splice variants using genome-wide expression data indicates 
considerable transcript diversity, with at least 6 of its 17 exons subject to regulated 
alternative splicing in humans 24 and mouse 25. Aceview (accessed on 4/4/13) annotates 
at least 25 possible translated isoforms but in most cases combinations of splicing events 
are unconfirmed, and represent the minimal non-redundant assemblies. Exclusion of 
complete or partial exons has been reported to be associated with disease states but, 
although impact on protein localization is documented for some, their effect on cellular 
function is not known 21,23,24,26-28. Here we show that, like its interaction partner cyclin E 13, 
CIZ1 is recruited to the DNase1 and high-salt resistant NM fraction upon induction of 
differentiation in murine embryonic stem (ES) cells (Fig. 1A). However unlike cyclin E, this 
transition in immobilisation is accompanied by complex changes in isoform expression, 
revealed by a change in the protein species reactive with polyclonal antibody 1793 
(raised against recombinant CIZ1 RD 17. Notably only two of these isoforms are detected 
in the NM fraction, with the rest being extracted at different stages of NM isolation. Similar 
sized isoforms to those detected in the NM fraction in differentiated ES cells are observed 
in NIH3T3 cells, and one is retained in the NM fraction after extraction (Fig. 1B) 19. This is 
observed in sub-nuclear foci after removal of chromatin (Fig. 1C), indicating a spatial 
arrangement maintained by attachment to the NM. NIH3T3 cells are used in subsequent 
experiments to investigate immobilization of CIZ1. 
 
Our previous analysis showed that NM attachment is mediated by domains encoded in 
the C-terminal third of full-length CIZ1 referred to as Cterm275 19 or anchor domain (AD, 
23, though notably this fragment is not sufficient to specify the focal patterning seen with 
endogenous CIZ1 or full-length recombinant GFP-CIZ1 17. Moreover others have reported 
a contribution to NM binding from sequences encoded by exon 8 26 which is outside of 
this region, suggesting that aggregation into nuclear foci may be a complex process that 
involves more than one immobilization event. Here we show that AD possesses a potent 
dominant negative capability that interferes with assembly of recombinant GFP-CIZ1 into 
sub-nuclear foci, while leaving intact its ability to form detergent and high salt-resistant 
attachments (Fig. 2B). Moreover, within 24 hours of transfection, GFP-AD causes 
displacement of endogenous CIZ1 foci from the NM (Fig. 2C, D). While endogenous CIZ1 
foci remain in the nucleus and intact (albeit against a diffusely stained background that is 
not present in control cells), extraction with DNase1 reveals that they are no longer 
attached to the NM and are instead depleted along with chromatin (Fig. 2D). This 
suggests that sequences encoded within GFP-AD can act to disengage previously 
formed NM attachments, and might therefore have the capability to facilitate a resetting or 
remodelling process. 
 




As well as CIZ1 and cyclin E, some of the proteins that play a direct role in initiation of 
DNA replication as part of the pre-RC are also partially or transiently associated with the 
NM. This has been reported for ORC1, part of the six subunit origin recognition complex, 
which appears to support transient NM recruitment of the rest of the ORC complex in G1 
phase 8,29, for CDC6 during G1 or early S-phase but not in G2/M 7, and for CDT1 in G1 
phase but not S or G2/M 9. For the mini-chromosome maintenance (MCM) complex the 
published evidence is not yet convincing. What is emerging clearly from the literature 
(reviewed in 30, is that reports differ depending on the cell type in which the analysis is 
carried out. This prompted us to undertake a small survey of a representative set of cell 
lines derived from tumours and from non-tumour tissue, looking at NM recruitment of 
CDC6 and MCM2 in asynchronous populations of cells by western blot. Overall, we find 
that in four cancer cell lines none of these factors are evident in the NM fraction (Table 1), 
whereas in four non-cancer cell lines at least one of them is detectable, though often only 
as a small fraction of the total cellular compliment (Table 1 and Fig. 3A). This is 
consistent with previous reports that support the idea that the pre-RC is normally 
transiently associated with the NM around the time of initiation of DNA replication, though 
contrary to the majority of published data which tends to report only on the dominant 
insoluble fraction, or is carried out in cancer cells. As with our analysis of cyclin E 13 and 
CIZ1 (below), the partitioning of these pre-RC components suggests a fundamental 
difference between cancer and non-cancer cells, and is consistent with the idea that the 
compartment in which they exert their function in DNA replication may be compromised 
or blocked in the cancer cell nucleus. 
 
Using CDC6 in NIH3T3 cells as a clear and robust output, we tested the effect of CIZ1 
AD on NM immobilization of the pre-RC. Transfection with GFP vector had no impact on 
the location or extractability of CDC6, with DNase 1-resistant protein evident in the 
nucleus of the late G1/early S phase fraction of a cycling population of cells (21%, Fig. 3B 
upper panels). However, GFP-AD rendered the nuclear CDC6 in these cells sensitive to 
extraction (0%, Fig. 3B, lower panels). These findings were confirmed by western blot 
(Fig. 3C). Thus, the dominant negative effect that CIZ1 AD has on NM attachment of 
endogenous CIZ1 also applies to CDC6, and possibly therefore the sub-nuclear 
compartment in which the pre-RC exerts its function in initiation of DNA replication. 
 
Detachment of CDC6 from the NM had no gross effect on cell cycle profile after 24 hours 
(Fig. 3D). The absence of any detectable effect on S phase progression argues that NM 
recruitment is not a requirement for initiation or elongation, and is consistent with the 
facts that i) CIZ1 can promote initiation in vitro in the absence of AD 17, and ii) none of the 
components we have studied (cyclin E, CIZ1, pre-RC) appear to be immobilized in cancer 
cells. We suggest that the functional consequence of NM attachment is not in facilitating 




the initiation process itself, but in maintaining and stabilizing genome configurations 
within a cell lineage, effectively hardwiring it for its chosen purpose. 
 
Consistent with the idea that immobilization of initiation of DNA replication on the NM is 
not an obligate function, CIZ1 is not immobilized in cancer cells. Using the RD-specific 
antibody 1793 17 we observed a consistent pattern of expression and sub-cellular 
localization in a panel of cancer cells, that is fundamentally different to cells derived from 
normal tissues. In normal cells, including human Wi38 (Fig.4A), MRC5, HFL1 and IMR90 
(not shown), NIH3T3 (Fig. 1B) and mouse ES cells induced to differentiate in vitro (Fig. 
1A), a large proportion of RD fractionates with the DNase1-resistant NM, and resides 
almost exclusively in sub-nuclear foci. However, in all seven cancer cell lines tested, RD 
protein was highly over-represented compared to non-cancer cells (Fig. 4A); shown for 
HeLa (cervical carcinoma), H727 (lung carcinoid) and T24/EJ (urothelial cancer) cells. 
Similar results were obtained for SBC5 (neuroendocrine lung cancer), U2OS 
(osteosarcoma), and RT4, RT112 (urothelial cancer). More importantly, in the cancer 
cells RD protein is not anchored to the NM (Fig. 4A, B), and is instead susceptible to 
extraction with DNase1, either completely (example T24/EJ cells) or leaving behind a 
small fraction comparable to the total amount in normal cells (example HeLa). Thus, in 
the cancer cell lines there exists a large pool of CIZ1 RD that is not constrained by 
attachment to the NM.  
 
Despite this failure to attach to DNase1-resistant structures, the AD domain of CIZ1 is in 
fact expressed in these cancer cell lines and can be detected with domain-specific 
antibody 2C, raised against a peptide encoded by exon 14 (Fig. 5A). Critically under 
conditions where RD protein is fully extracted (for example EJ cells), AD remains 
immobilized on the NM, indicating that it is present under some circumstances in a form 
that is uncoupled from RD. This is direct evidence of uncoupled domain expression.  
Furthermore in contrast to RD, AD protein levels are broadly similar between these 
example cancer and normal cell lines (Fig. 5B, C) again implying regulation that is 
independent from RD. Consistent with this protein level information, at the transcript level 
AD and RD are similarly expressed in non-cancer cells, but are elevated and strikingly 
uneven in most of the cancer cell lines (Fig. 5D). Thus, uncoupled domain expression 
also occurs at the transcript level. Transcripts that skip internal sequences that encode 
RD are notable amongst CIZ1 expressed sequence tags isolated from tumour tissue (for 
example BE300131, BF306155, BU538884), suggesting that aberrant splicing may be 
driving imbalanced expression in the tumour context.  
 
Discussion   Despite many of the same players, the specification of replication origins is 
fundamentally different in higher and lower eukaryotes. In yeast, specific DNA sequences 




identify origins of replication from which surrounding DNA is duplicated. In higher 
eukaryotic cells, replication origins are less precisely defined by DNA sequence, with 
context having an apparently greater influence. At the simplest level this means 
chromatin conformation, including epigenetic modification of DNA or associated proteins. 
However in spatial terms, ‘context’ may well be specified by the functional relationship 
between chromatin and the NM. There is also a dichotomy in the mechanism of origin 
selection during Xenopus embryogenesis, where a shift occurs at the mid-blastula 
transition from frequent, random initiation events at short intervals, to fewer events with 
preference for particular sites 31. Our previous analysis of the immobilization of cyclin E in 
the developing Xenopus embryo mirrors this transition 13, and suggests that initiation of 
DNA replication becomes immobilized on the NM around the time when more precise 
selection criteria begin to specify origins. Normally in somatic cells initiation from 
individual origins progresses with a defined spatial and temporal pattern, and in higher 
eukaryotes there is a strong relationship between this and gene expression 32, or 
transcription factor binding 33. If this pattern is maintained by immobilization on the NM, 
failure to attach could have a chronic destabilizing effect which impacts on the epigenetic 
control of gene expression.  
 
The picture that emerges from the data presented here, and from the published evidence, 
is that CIZ1 plays a role in initiation of DNA replication by acting as both a NM anchor and 
a coordinator of cyclin function at the pre-RC. This has important implications for the 
spatial organisation of DNA replication and the mechanism by which pattern is stabilised. 
We suggest that the changes in CIZ1 expression that we have observed in cancer cell 
lines would give rise to spatially unconstrained DNA replication, and possibly therefore a 
pathogenic failure to stabilize cell-type specific genome configurations. We already know 
that RD has the capacity to promote DNA replication when not attached to the NM, 
because truncated forms that lack AD can function in vitro and are actually more effective 
than CIZ1 forms that posses NM interaction domains, indicating that immobilization is a 
constraining feature rather than one that is intrinsic to function 17. Therefore, expression 
of excess unconstrained RD in tumours could support cyclin-mediated functions at 
locations that are not specified by attachment to the NM. Notably, the impact of excess 
AD could be very similar to that of excess RD. When NM-binding domains are expressed 
in the context of a protein that cannot support cyclin recruitment, such a protein could 
compete for docking sites on the NM. The present analysis suggests that this may in fact 
be the case and that CIZ1 AD possesses a dominant negative capability that impinges 
not only on CIZ1 itself but also the pre-RC. This capability offers a mechanism by which 
recruitment of replication origins might be regulated during normal differentiation, offering 
flexibility to detach and re-establish attachments with an altered configuration. 
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Figure legends  
Fig. 1 CIZ1 is associated with the nuclear matrix in differentiating mouse ES and NIH3T3 
cells. A) Western blot of protein fractions derived from murine ES cells before and after 
differentiation, showing total CIZ1 (T), the proportion that is detergent-resistant (P) and 
detergent soluble (SN), the products released by a salt wash (w) of the detergent-
resistant pellet, prior to digestion with DNase 1 (P, SN), or mock incubation in the 
absence of DNase 1 (P, SN). The extent of histone H3 released into the DNase 1 SN 
fraction shows the efficiency of chromatin digestion. CIZ1 is detected with antibody 1793 
17. Evidence of the differentiation status of these samples was published previously 13. B) 
Western blot shows similar analysis for NIH3T3 cells, and images show CIZ1 (red) in 
unextracted nuclei and after extraction to reveal detergent-resistant or DNase 1-resistant 
CIZ1, as indicated. Nuclei are counterstained with H33258 (blue). Bar is 10 !m.  
 
Fig. 2 Dominant negative activity of CIZ1 anchor domain. A) Representation of CIZ1, 
showing exons that encode the fragment used to raise polyclonal antibody 1793 (red), 
domains that code for DNA replication activity (RD, 17,20, nuclear matrix anchor domain 
(AD), and two putative nuclear localization sequences predicted by http://wolfpsort.org/ 
(black stars). The fragment referred to as GFP-AD is shown below (also known as C-term 
275 19. B) Histograms show the proportion of NIH3T3 cells with nuclear fluorescence (± 
SEM) after transfection with GFP-CIZ1, GFP-AD or equivalent amounts of each as a co-
transfection for 24 hours. ‘U’ refers to cells that were not extracted prior to fixation, ‘Det’ 
refers to cells with detergent-resistant GFP in the nucleus. ‘D’ denotes defuse pattern and 
‘F’ (red columns) denotes focal pattern. ‘S’ refers to cells with 0.5 M NaCl-resistant GFP 
in the nucleus. Images show pattern of nuclear fluorescence after extraction with 
detergent in individual nuclei at high resolution (upper panels) and in populations of cells. 
DNA is blue, bar is 10 !m. C) Immunofluorescence analysis of CIZ1 (red, detected with 
1793), after transfection with GFP-AD or GFP control, and extraction with detergent or 
DNase 1 as indicated. DNA is blue. Note the lack of DNase-resistant CIZ1 nuclear foci in 
cells transfected with GFP-AD. D) High-magnification images of endogenous CIZ1 in 
cells transfected and extracted as indicated. Bar is 2 !M. 
 
Fig. 3 CIZ1 anchor domain displaces endogenous CDC6 from the nuclear matrix. A) 
Western blots showing subcellular fractionation of three normal tissue-derived cell lines, 
and the location of pre-replication complex proteins CDC6 and MCM2. Histone H3 is 
shown as a control for DNase 1 digestion. Summary results for these and other cell lines 
are given in Table 1. Labels are defined in Fig.1. B) CDC6 (red) in NIH3T3 cells 24 hours 
after transfection with GFP-AD or GFP alone (green), after extraction with detergent or 
DNase 1, as indicated. Nuclei are blue. Bar is 10 !m. The proportion of cells with 




DNase1-resistant CDC6 falls from 21% to 0% in cells transfected with GFP-AD. C) 
Western blot showing the behaviour of the detergent-resistant fraction of CDC6 after 
extraction with DNase 1, in NIH3T3 cells without and with expression of ectopic GFP-AD 
as indicated. D) Flow cytometry showing DNA profile of NIH3T3 cells transfected with 
GFP-AD or GFP, after staining with propidium iodide as described previously 17. 
 
Fig. 4 Cancer cells contain CIZ1 replication domain (RD) that is not immobilized on the 
nuclear matrix. A) Representative immunofluorescence images of CIZ1 RD (red, detected 
with 1793) in three cancer cell lines showing total protein in unextracted cells, and 
antigen remaining after removal of the soluble fraction (Detergent) and chromatin-bound 
fraction (DNase). A non-cancer lung cell line (WI38) is shown for comparison. DNA is 
stained with Hoechst 33258 (blue). Bar is 10 !m. Images were collected under identical 
conditions, so that within and between cell lines the intensity of CIZ1 and DNA reflects 
the levels remaining in the cell. These cancer cell lines and four others (not shown) 
contain excess CIZ1 that is not attached to the nuclear matrix. B) Western blot analysis of 
fractionated cancer cells as described in Fig. 1. Histone H3 is shown as a control for 
DNase 1 digestion, and the nuclear matrix fraction is indicated. 
 
Fig. 5   Cancer cells express CIZ1 anchor domain that is immobilized on the nuclear 
matrix. A) Representation of CIZ1 showing the location of the antigenic peptide used to 
generate anchor domain antibody 2C (green), and two qRT-PCR primer/probe sets in 
exons 6/7 (red) and exon 16 (green). B) Immunofluorescence images of CIZ1 AD (green, 
detected with 2C) in two cancer cell lines showing total protein in unextracted cells, and 
antigen remaining after removal of the soluble fraction (Detergent) and chromatin-bound 
fraction (DNase). DNA is stained with Hoechst 33258 (blue). Bar is 10 !m. C) Similar 
analysis of non-cancer line WI38. Anchor domain is present and immobilized to some 
extent in all cell lines. D) Relative quantification of CIZ1 RD (red) and CIZ1 AD transcripts 
(green), after normalization to actin and calibration to RD in normal cell line Asf1, which is 
given an arbitrary value of 1. Analysis was performed in triplicate and is shown ± SEM. E) 
Ways in which uncoupled expression of CIZ1 RD and AD could influence the sub-nuclear 
localization of its DNA replication activity. The model assumes that nuclear matrix-
associated docking sites are limiting, so that uncoupled AD blocks assembly of CIZ1 on 













Table 1  The location of pre-RC components CDC6 and MCM2, in sub-cellular fractions 
generated from cancer cell lines (HeLa; cervical carcinoma, EJ; bladder cancer, H727; 
lung carcinoid, LNCAP; prostate cancer) and non-cancer cell lines (ARPE19, MCF10a, 
MRC5, 3T3), using the western blot protocol used in Figs. 1, 3, 4. The proportion of 
protein in key fractions is indicated by the key and is shown in relation to signal intensity 
in the total fraction (whole cell lysate). ‘Chromatin’ refers to protein detected in the 
DNase1 supernatant, and ‘nuclear matrix’ refers to protein in the DNase1 pellet fraction. 
























ARPE19 CDC6        HeLa CDC6      
 MCM2         MCM2      
 Cyclin E        Cyclin E      
MRC5 CDC6   ND   ND   ND  EJ CDC6     
 MCM2         MCM2      
 Cyclin E   ND   ND   ND   Cyclin E      
MCF10a CDC6        H727 CDC6      
 MCM2         MCM2     
 Cyclin E  ND  ND  ND   Cyclin E      
3T3 CDC6     LNCaP CDC6      
 MCM2      MCM2      
 Cyclin E      Cyclin E      
           
 high  medium  low  None  
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Relationship between DNA replication and the nuclear
matrix
Rosemary H. C. Wilson and Dawn Coverley*
Department of Biology, University of York, Heslington, York YO10 5DD, UK
There is an extensive list of primary published work related to the nuclear matrix (NM). Here we
review the aspects that are required to understand its relationship with DNA replication, while
highlighting some of the difficulties in studying such a structure, and possible differences that
arise from the choice of model system. We consider NM attachment regions of DNA and discuss
their characteristics and potential function before reviewing data that deal specifically with func-
tional interaction with DNA replication factors. Data have long existed indicating that newly
synthesized DNA is associated with a nuclease-resistant NM, allowing the conclusion that the
elongation step of DNA synthesis is immobilized within the nucleus. We review in more detail
the emerging data that suggest that prereplication complex proteins and origins of replication
are transiently recruited to the NM during late G1 and early S-phase. Collectively, these data
suggest that the initiation step of the DNA replication process is also immobilized by attachment
to the NM. We outline models that discuss the possible spatial relationships and highlight the
emerging evidence that suggests there may be important differences between cell types.
Introduction
The nuclear matrix
Descriptions of an insoluble proteinaceous nuclear
substructure, in some ways analogous to the cytoskel-
eton, have existed for at least 40 years. However, the
difficulties associated with studying this nuclear frac-
tion mean that there are still many unanswered ques-
tions about structure and function; and even some
residual controversy about its very existence. How-
ever, there is now a large and growing body of evi-
dence in favor of such a nuclear substructure. Here
we review the published work on its relationship
with DNA replication.
The nuclear substructure has been termed the nuclear
matrix (NM), the nuclear scaffold or the nuclear skele-
ton (or nucleoskeleton) depending on the technique
used to reveal it. These are, respectively, extraction with
high salt (2.0 M NaCl) (Berezney & Coffey 1974), lith-
ium 3,5-diiodosalicylate (LIS) (Mirkovitch et al. 1984)
or after encapsulation in agarose under physiologically
relevant salt concentrations and electrophoresis (Jackson
& Cook 1988). A protein is termed part of the nuclear
substructure if it resists extraction. However, there are
also many variations of these techniques (reviewed in
Martelli et al. 2002), and this means that interpretation is
not always straightforward. Here we use the term NM
as an overarching term and aim to consolidate the
reported observations to outline some general phenom-
ena. Depending on extraction technique, the residual
protein fraction varies slightly in composition but the
core components revealed by several large-scale screens
are similar (Albrethsen et al. 2009; Varma & Mishra
2011; and references therein). These include lamins,
matrins, hnRNPs, other ‘structural’ proteins, and vari-
ous proteins involved in DNA metabolism, many of
which are listed and categorized in a database of NM
Proteins, NMPdb (Mika & Rost 2005).
Very early work described a proportion of nuclear
proteins as unextractable with high salt (reviewed in
Martelli et al. 2002) however, the idea of a NM
really began with electron micrographs (EM) showing
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a network of fibers that remain within the nucleus
after extraction (Berezney & Coffey 1974). The con-
troversy associated with NM research appears to be
attributable to two key reasons. First, it has proved
difficult to show such a framework as that seen by
EM using immunofluorescence methods in unextract-
ed cells. Instead immunofluorescence against candi-
date NM proteins usually reveals a pattern of
punctate spots (reviewed in Martelli et al. 2002). One
study used electron spectroscopic imaging (ESI) to
view unextracted nuclei by electron microscopy with
the aim of identifying areas as protein and/or nucleic
acid rich. Using paraformaldehyde fixed sections, this
showed inter chromosomal areas to be composed of
protein rich but nucleic acid poor structures, consis-
tent with the description of a NM (Hendzel et al.
1999). Also worth consideration when thinking about
the NM is the idea that there may exist multiple local
NMs (Martelli et al. 2002) that are dynamic and
capable of altering characteristics and composition
based on the nuclear processes occurring at that point
in time and space (Nelson et al. 1986). Therefore, we
might not expect to see filamentous structures com-
posed of a small number of specific proteins, but
instead transient associations between functional pro-
teins and a ‘core’. The use of nonphysiological condi-
tions, in particular high salt extraction, has been
criticized as potentially causing aggregation of such
protein assemblies (Pederson 1998). To address this,
the LIS and physiologically relevant buffer techniques
were developed, which give very similar results.
The second major reason that appears to have
added complexity and contributed to the controversy
in the NM field is the widespread use of systems that
now appear to lack or possess a different kind of
NM, such as Xenopus eggs, cancer cell lines, and pro-
genitor cells. Recent research suggests that the NM
changes as cells differentiate or become transformed
(reviewed in Zink et al. 2004; Munkley et al. 2011,
and discussed in more detail below).
We will not review evidence for the NM as this
has been extensively evaluated elsewhere (Pederson
1998; Hancock 2000; Nickerson 2001; Martelli et al.
2002). Instead we consider its functional significance.
The NM has been proposed as an anchor for DNA
structure, the site of transcription (Jackson & Cook
1985), DNA repair (Qiao et al. 2001), splicing (Zeit-
lin et al. 1987), chromatin remodeling (Reyes et al.
1997), and DNA replication (Jackson & Cook
1986b). Here, we aim to describe how a NM could
support DNA replication and discuss proposed mech-
anisms and models.
Structural organization of DNA
In order to fit approximately 2 m of DNA within a
mammalian nucleus of the order of 10 lm in
diameter, it is clear that there must be multiple lev-
els of organization. The extremes of packing of
DNA, from wrapping the double helix around his-
tone octamers to form nucleosomes, to compartmen-
talization into chromosome territories (reviewed in
Cremer et al. 2006) are now as accepted as the helix
itself. However, intermediate levels of organization
incur more debate (reviewed in Bian & Belmont
2012).
One model is that nucleosomes are organized into
a 30 nm fiber. However, existence of this structure in
vivo is still hotly contested as the evidence is largely
from in vitro work (Bian & Belmont 2012). An alter-
native model is that of fractal globules (reviewed in
Fudenberg & Mirny 2012), in which short regions of
DNA are proposed to ‘crumple’ (condense) together
to form a series of globules (or domains). These then
further crumple together to form larger globules,
repeating until they achieve the size of chromosome
territories. Some key points of this model are that
DNA is not knotted as it would be in an equilibrium
globule model (random compaction of DNA), and
that it includes all the required levels of compaction.
In this model, spatially segregated domains would
suggest flexible access to each region of DNA. There
are supportive data for the idea of domains within
domains, from Fluorescence In Situ Hybridisation
(FISH) and Chromosome Conformation Capture
techniques (Lieberman-Aiden et al. 2009). Consistent
with both of the above, chromatin loops are thought
to periodically attach to the NM. It is likely that the
true state of chromatin is a combination of these pro-
posed higher order structures and is likely to be
highly dynamic. Here we focus primarily on the
organization inherent in attachment to the NM.
Attachment of DNA to the nuclear matrix
Attachment to a proteinaceous structure was first
observed by electron microscopy in the 1970s (Paul-
son & Laemmli 1977). Various methods have been
used to study the DNA : NM attachment points
(Mirkovitch et al. 1984) including imaging by FISH
and Maximum Fluorescence Halo Radius (MFHR)
(Fig. 1), and biochemical (digestion of loop DNA
with restriction enzymes, DNase I or topoisomerase
II). Early studies showing attachment of DNA to the
NM led to the idea of periodic attachments and the
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concept of intervening chromatin loops (Benyajati &
Worcel 1976; Marsden & Laemmli 1979) (Fig. 2A).
Subsequent work has led to a modification to include
loops of different sizes (Fig. 2B) and likely different
functions (described in more detail below).
Attachments are termed MARs (matrix attached
region), which are resistant to extraction with high
salt, scaffold attached region (SARs), which are resis-
tant to extraction with LIS, or skeleton-attached
sequences, which are resistant to physiological buffers
after encapsulation in agarose, all coupled with enzy-
matic digestion of DNA. The attachment points
revealed by different extraction methods have signifi-
cant overlap but some are method specific. For
example, only approximately half of sequences
revealed as MARs on chromosomes 14–18 were also
identified as SARs (Linnemann et al. 2009). It is
likely that the total attachment points in a cell com-
prise a combination of those revealed by these tech-
niques. We first discuss general features of attachment
regions, for which we use the overarching term
S/MAR, before highlighting some differences
between MARs, SARs and skeleton-attached
sequences.
!"#$%&'( )*+,*-$./&,*0 12+-3
Figure 1 Newly synthesized DNA (A) Left: example of Max-
imum Fluorescence Halo Radius image from NIH3T3 cell
showing DNA loops stained with DAPI emanating out from
the nuclear matrix (NM) (MFHR method described in
Buongiorno-Nardelli et al. 1982; Guillou et al. 2010). Right:
newly synthesized DNA is observed at the NM but not visible
in loop DNA. Cells were pulsed for 30 min with BrdU and
visualized with a-BrdU. Centre: merged image showing BrdU














Figure 2 Possible relationships between DNA replication and the nuclear matrix (NM). (A) DNA is thought to be periodically
attached to the NM at S/MARs forming intervening chromatin loops. (B) Refined model illustrating variable loop sizes and com-
plex S/MAR usage including utilized S/MARs and function-related alternative potential S/MARs. (C) Our preferred model
showing attachment to the NM via nonorigin S/MARs, and recruitment of DNA replication origins at G1/S-phase with possible
impact on loop size. (D) Alternative representation of chromatin loops showing replication origin clustering within a DNA replica-
tion factory, with no representation of NM attachments.
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The length of DNA that is associated with the
NM at each attachment point is variously reported as
between 100 and 1000 bp with individual loops
ranging from 4 to 200 kbp (Vogelstein et al. 1980;
Buongiorno-Nardelli et al. 1982; Singh et al. 1997;
Bode et al. 2003). From our data, we calculate an
average loop size of 70 kbp in noncancer differenti-
ated mammalian cells (Wilson, R.H.C., and Cover-
ley, D., our unpublished observation), which ties in
closely with several of the previous estimates in the
60–86 kbp range (Vogelstein et al. 1980; Jackson
et al. 1990). With a human haploid genome of
~3 billion bp, this would suggest that ~86 000 attach-
ment points exist at any one time per diploid, G1
cell. As different S/MARs exist in different cell types,
and most likely in different phases of the cell cycle
and transcriptional programmes, the total number of
potential S/MARs is likely to be much more than
this (Fig. 2B). Boulikas (1995) predicted approxi-
mately 100 000 potential S/MARs based on (i) a
loop size of 60 kbp, (ii) an estimated genome size of
3.6 billion bp, and (iii) the fact that some S/MARs
are facultative (Boulikas 1995). As we will discuss,
predictive tools for S/MARs have their limitations,
but it is interesting to note that all tools appear to
overpredict S/MARs (Platts et al. 2006). While we
cannot currently differentiate between false positives
and facultative S/MARs, a surplus of potential S/
MAR regions would allow for flexibility in usage and
imply some form of selection. Consistent with these
ideas, it has been shown that a sequence that has the
potential to be a functional S/MAR is not always
recruited to the NM (Heng et al. 2004).
Features of S/MARs
Many of the S/MARs that have been identified arise
from studies at a particular gene or locus, and there
have been few chromosome or genome wide investi-
gations. The collation of S/MARs identified by indi-
vidual groups into the S/MAR database (Liebich
et al. 2002a) has allowed comparison of potential S/
MAR motifs (Liebich et al. 2002b). However, other
than an over-representation of As and Ts, the authors
found little sequence similarity. Instead, structural
motifs are thought to play a greater role in determin-
ing the potential for NM attachment. One predictive
tool, ‘MAR finder’ uses combinations of the follow-
ing structural motifs to predict S/MARs; origins of
replication, TG-rich sequences (commonly in 3!
UTRs), curved DNA, kinked DNA, topoisomerase
II sites, and AT-rich sequences (Singh et al. 1997).
Other suggested characteristics include transcription
factor binding sites and other regulatory sequences
linked with promoter function (Singh et al. 1997).
However, some reports are contradictory and motif
enrichment may depend on the method used to
remove loop DNA. Moreover, the predictive power
of tools that use a combination of structural motifs
and AT-rich DNA is little better than prediction
based on AT-content alone (Evans et al. 2007). One
of the reasons for the lack of a good predictive model
is that only a few S/MARs have been identified by
different methods, which appear to identify different
populations. So while a particular motif may appear
common to one set of identified S/MARs, it may
not be hugely predictive of S/MARs in general. It
may also be that many motifs can increase the
probability of a region forming NM attachment with
each increasing the probability only slightly. There-
fore, the identification of more S/MARs and a better
understanding of their function will be necessary in
order to develop better predictive tools.
Functions of S/MARs
In spite of difficulties identifying and predicting
S/MARs, several different functions have been sug-
gested for these NM attachments. Constitutive
attachments, which do not vary by cell type, are sug-
gested to have a structural role in anchoring the
DNA and maintaining nuclear architecture. Consis-
tent with this organizational function, territories have
been shown to remain after extraction to reveal the
NM but be lost when the NM is disrupted with
RNase (Ma et al. 1999). In contrast, other S/MARs
appear to be transient and facultative in their attach-
ment to the NM. Some vary by cell type and are
thought to be involved in maintaining the
transcriptional programe, and others vary with exter-
nal signals and the subsequent change in transcrip-
tional programe. These include S/MARs associated
with transcription units, enhancers, and transcription
factor binding sites. Furthermore S/MARs vary by
cell cycle stage and include regions at potential ori-
gins of replication. We describe below, evidence that
both transcription and replication occur at the NM.
The facultative S/MARs that are implicated in these
processes are likely to be involved in the recruitment
of specific regions to the NM. Consistent with the
idea of constitutive and facultative S/MARs, some
proteins which bind S/MARs (MARBPs) are core
components of the NM, such as matrins and lamins,
topoisomerase II and high-mobility group proteins,
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while others are cell type or signal specific, such as
Scaffold Attachment Factors A (SAF-A) and B (SAF-
B) and SATB1 (reviewed in Wang et al. 2010).
Attachment regions could be grouped by charac-
teristics, namely motif composition, extraction
method or function. For example, some investigators
have advocated a classification of S/MARs into the
following four groups based on: regulatory elements
including origins and enhancers (class I), somatic cell
boundary elements (class II), haploid genome bound-
ary elements observed in sperm (class III), and those
with intermediate affinity with the NM (class IV)
(Kramer & Krawetz 1996). Although this scheme
does not appear to be in widespread use, it effectively
classifies S/MARs by motif or structure and by con-
text dependent factor binding.
It is possible that classification by motif or extrac-
tion method reveals the same groups. For example,
matrix attachment regions (MARs) may contain spe-
cific motifs and be related to a specific function.
Alternatively, one feature may be more important
and, using this example, MARs may encompass
regions with different function. We now describe
reports from two groups that investigated whether
the attachments revealed by different methods specify
function.
One study used chromosome paints to compare
MARs, SARs, and skeleton-attached sequences gen-
ome-wide in human lymphoblasts (Craig et al. 1997).
Cells were extracted with either 25 mM LIS, 2.0 M
NaCl or physiological buffers after agarose encapsula-
tion, and loop fragments released using restriction
enzyme digestion. Loop and attached DNA fragments
were separated and fluorescently labeled and then
used in combination as FISH chromosome paints. It
is important to note that the resolution for this study
is in the megabase range and that metaphase chromo-
somes were used. Nevertheless, the study found
MARs to be slightly enriched in gene poor regions
and relatively absent from transcriptional promoters,
and SARs were also enriched in gene poor regions,
whereas skeleton-attached sequences were associated
with gene rich regions and CpG islands. The authors
found little change in SARs between mitotic and
interphase chromatin but considerable difference
when looking at MARs or skeleton-attached
sequences. Overall, the data suggest that SARs are
constitutive and structural. In contrast, MARs appear
to vary by cell cycle phase but not transcriptional sta-
tus, whereas skeleton-attached sequences varied by
cell cycle phase and in addition appear to be linked
to transcription.
In other studies, MARs and SARs of chromo-
somes 14–18 of HeLa and primary aortic adventitial
fibroblasts (AoAF) were compared using a microarray
approach with much finer resolution than imaging
approaches (Linnemann & Krawetz 2009b; Linne-
mann et al. 2009). Regions enriched in the attached
DNA fraction relative to loop fraction were
designated as MARs or SARs depending on the
method of extraction. For both types of cell, MARs
were generally found in intergenic and gene poor
regions and were strongly associated with silenced
genes, comparing well with data from Craig et al. In
comparison, SARs density did not depend on gene
density but tended to overlap genes and be associated
with expressed genes. Linnemann et al. propose
MARs to be structural with a subset of intragenic
MARs providing silencing attachments, and SARs to
be facultative and related to function, especially tran-
scription. This suggests that control of gene expres-
sion is achieved through multiple mechanisms which
include MAR attachment and histone modifications
and other epigenetic marks (Linnemann & Krawetz
2009b).
The lack of more genome wide studies makes
definitive statements about subgroups of S/MARs
and their function difficult. However, general conclu-
sions from these studies suggest MARs to include
structural and silencing attachment points, SARs to
perhaps be important for cell type determination and
maintenance, and SARs and/or skeleton-attached
sequences to be important for gene expression.
DNA replication and the nuclear matrix
Various lines of evidence suggest that DNA replica-
tion occurs in association with the NM. Origins of
replication are recruited to the NM, but as yet there
is little indication which subgroup they are likely to
fall into. Both newly synthesized DNA and termina-
tion structures exist within NM fractions, DNA repli-
cation origins appear to be facultative S/MARs, and
a number of key proteins involved in replication are
themselves associated with the NM. We will discuss
evidence for elongation, termination, and initiation of
DNA replication.
Elongation of DNA replication
Biochemical fractionation of nuclei to localize nascent
DNA, or visualization after labeling with short pulses
of nucleotide analogues, has shown newly synthesized
DNA and replication intermediates to be located at
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the NM and crucially not in the loops (Fig. 1). Fur-
thermore, pulse-chase experiments show that when
newly synthesized DNA is observed at later time-
points, it has migrated from the NM fraction into
loop regions (Pardoll et al. 1980; Vogelstein et al.
1980; Jackson & Cook 1986b; Nakayasu & Berezney
1989; Gerdes et al. 1994). This collection of studies
indicates that the DNA synthesis step and presumably
therefore also replication forks are located at the NM.
Consistent with this, S-phase cells possess both prolif-
erating cell nuclear antigen (PCNA) and DNA poly-
merase a in the nuclear skeleton fraction (Hozak
et al. 1993, 1994). Moreover, this population of poly-
merase a showed in vitro activity that was comparable
to that in vivo, and nascent DNA remained associated
with the skeleton (Jackson & Cook 1986a,b). Similar
conclusions were drawn from analysis of NM prepa-
rations (Nakayasu & Berezney 1989).
Termination of DNA replication
Relatively little is known about the termination of
DNA replication; however, there are data that suggest
an association with the NM. First, topoisomerase II is
located at the NM (Berrios et al. 1985) and appears
to be required for resolving replication intermediates.
More direct evidence comes from analysis of NM
attached DNA, by 2D agarose gel electrophoresis,
which revealed termination structures in addition to
replication intermediates. Patterns were consistent
with both termination at specific points and as a con-
sequence of the convergence of forks (Little et al.
1993).
Initiation of DNA replication
The most direct evidence that initiation of DNA rep-
lication is located at the NM makes use of synchron-
ised late G1-phase cells treated with DNase I to
remove chromatin loops (Radichev et al. 2005).
When incubated in soluble extract from S-phase cells
(which contains regulatory protein kinases that induce
initiation) more DNA synthesis occurred on the
residual NM-associated chromatin than in control
incubations that only support elongation. This indi-
cates that NM-attached chromatin from late G1 cells
can undergo initiation. Because this was found to be
both located within characteristic foci and dependent
on protein kinase activity, these data support the idea
that the initiation step of DNA replication occurs in
chromatin that is protected by association with a
nuclease-resistant structure.
Interestingly, under the same conditions, chroma-
tin-depleted early G1 nuclei did not undergo kinase
dependent initiation. This may be due to incomplete
assembly of all required factors of the preinitiation
complex (pre-IC) or because origins are not located
at the NM during early G1. Data described below do
indeed suggest that origins are recruited to the NM
only during late G1. However, we cannot assume
that all origins are recruited to the NM together, as
this may occur in conjunction with their activation.
Origins of replication as S/MARs
In human cells, between 30 000 and 50 000 replica-
tion origins are thought to be activated per cell cycle
in a spatially and temporally ordered fashion. Saccharo-
myces cerevisiae origins of replication are defined by
DNA sequence, the autonomous replication sequence
(ARS). However, similar short sequences do not
specify origins in higher eukaryotes. Instead, struc-
tural information and epigenetic marks that can be
stably inherited by daughter cells play a role in speci-
fication. These include promoter status, CpG methyl-
ation, nucleosome positioning, DNase I sensitive
sites, DNA topology, and chromatin loop architec-
ture (reviewed in Mechali 2010). For example, there
is a higher probability of initiation occurring just
before or after transcription start sites, with and with-
out CpG-rich regions (Cayrou et al. 2011). Even in
S. cerevisiae the ARS, though required, is not suffi-
cient to specify origin use as contextual features are
known to play a role (Nieduszynski et al. 2006). The
apparently weak dependence on primary sequence
has made it difficult to predict higher eukaryote ori-
gins, although S/MARs have been identified in the
vicinity of origins of replication for a handful of
exemplar genes (reviewed in Cayrou et al. 2010).
Early experiments suggested that mammalian cell
origins were permanently associated with the NM
(Lagarkova et al. 1998; and references therein). Fur-
thermore, the similarity in size between replication
units and chromatin loops reported in the 1980s
(Buongiorno-Nardelli et al. 1982) suggested that they
might be one and the same, with all attachment
points being origins. In apparent support of this con-
clusion, regions of DNA labeled in early S-phase by
incorporation of nucleotide analogues are observed at
the NM fraction.
More recent evidence, however, suggests that
recruitment of origins of replication to the NM
occurs only transiently in late G1 and S-phase.
Attachment to the NM and nucleoskeleton has been
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investigated for the well-studied origin of replication,
oriB, at the dihydrofolate reductase (DFHR) locus in
Chinese Hamster Ovary (CHO) cells (Ortega &
DePamphilis 1998; Djeliova et al. 2001a,b). In one
study, DNA from CHO cells was separated into loop
and NM attached fractions (Djeliova et al. 2001a) and
then probed with the oriB sequence or with nascent
DNA from early S-phase (the collective origin frac-
tion). No enrichment of origins, either oriB or the
collective origin fraction, was observed in the NM
attached DNA from asynchronous cells (Djeliova
et al. 2001a). However, oriB was enriched in the NM
attached DNA (Djeliova et al. 2001b) and nucleoskel-
eton attached DNA (Ortega & DePamphilis 1998)
from late G1 phase cells (but not early G1), and lost
from this fraction as cells progressed through S-phase
(Djeliova et al. 2001b). In contrast to this early repli-
cating origin, the late replicating origin from the
b-globin gene was investigated in HeLa cells, where
the NM association was maintained through S-phase
(Djeliova et al. 2001b). Origins from other exemplar
genes have also been described to temporally associate
with the NM (reviewed in Ottaviani et al. 2008).
Collectively, these studies show that origins have the
potential to reside close to the NM, but that their
association is not constitutive, being recruited during
late G1 (Fig. 2C) and lost during S-phase.
Prereplication complex components
Potential DNA replication origins are marked by the
origin recognition complex (ORC1-6), then licensed
by recruitment of the rest of the prereplication com-
plex components (pre-RC), including cell division
cycle 6 (CDC6), chromatin licensing and DNA repli-
cation factor 1 (CDT1) and the mini-chromosome
maintenance complex (MCM2-7), and reviewed in
more detail elsewhere (Takisawa et al. 2000; Bell &
Dutta 2002). Additional proteins associate with the
pre-RC to form the pre-IC, which recruits the DNA
replication machinery itself (RC) (summarized in
Boos et al. 2012). We are not aware of any published
investigations of pre-IC components in relation to
the NM, but several report findings for pre-RC and
RC components.
Consistent with their role in the regulation of tem-
porally restricted events, pre-RC proteins have tightly
controlled temporal expression and degradation, as
well as restricted subnuclear localization. Unfortu-
nately, many researchers limit their analysis by failing
to include a nuclease digestion step in cellular extrac-
tion protocols, allowing only generalized conclusions
about association with chromatin and/or NM. Fur-
thermore, the cell cycle context of potential NM
recruitment means that the fraction detected may be
small and their recruitment to the NM may in fact be
cell-type specific making the overall picture difficult
to interpret. An important consideration to highlight
here is that pre-RCs are laid down at potential origins
(origin licensing) during late telophase in the mitotic
cell cycle (Dimitrova et al. 2002), but lost if cells
become quiescent (Madine et al. 2000; Tatsumi et al.
2003; Cook et al. 2004) necessitating their re-synthesis
and recruitment following cell cycle re-entry. There-
fore, the timing of both pre-RC formation and their
NM recruitment is likely to be different for the G1
after release from quiescence compared to the
G1-phase in the mitotic cell cycle. However, the
accumulation of increasingly sophisticated reports on
NM attachment of pre-RC components is beginning
to support the idea that some core components
become attached to the NM, possibly in particular
combinations and only around the time of initiation
of DNA replication.
The most widely used method to determine NM
recruitment of pre-RC proteins uses cytoskeletal buf-
fer (10 mM Pipes pH 6.8, 100 mM NaCl, 300 mM
sucrose, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT)
and fractionation by centrifugation (Ainscough et al.
2007). Soluble and insoluble proteins are recovered
following treatment with 0.1% Triton X-100, and
chromatin bound proteins are released by inclusion of
0.5 M or 2.0 M NaCl or subsequent treatment with
DNase I. NM bound proteins are defined as those
which are not released by any of these treatments.
This method can be carried out on cell populations,
for western blot analysis, and is also compatible with
immunofluorescence-based imaging. A further dis-
tinction can be made between those proteins that are
released from native cells but retained by those
treated with a protein cross-linker such as DTSP.
Chromatin bound proteins such as histones do not
remain in the DNase I resistant fraction in the pres-
ence of cross-linker but NM associated proteins do,
indicating direct interaction with a component of the
NM (Fujita et al. 2002).
Origin recognition complex
Data show stable levels of ORC subunits 2–5
throughout the mitotic cell cycle (Madine et al. 2000;
Fujita et al. 2002; Ohta et al. 2003; Tatsumi et al.
2003; McNairn et al. 2005), and one report suggests
this is also true for ORC1 (McNairn et al. 2005).
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However, the majority of reports show ORC1 to
peak in G1 phase with subsequent proteolysis during
S-phase and mitosis (Tatsumi et al. 2003). This
‘ORC cycle’ has been extensively reviewed else-
where (DePamphilis 2003).
Several studies have looked at the relationship
between ORC subunits and the NM. ORC1 has been
detected in the NM fraction of asynchronous popula-
tions of HeLa, BJAB, and BC3 cells (Kreitz et al. 2001;
Fujita et al. 2002; Ohta et al. 2003; Tatsumi et al.
2003; Ohsaki et al. 2009) and in Drosophila melanogaster
cells (Varma & Mishra 2011). Several investigators
have temporally resolved this NM association by cell
cycle phase, which revealed ORC1 to be enriched in
the NM fraction in G1, BJAB and BC3 cells, and G1
or from late G1 in HeLa cells (Kreitz et al. 2001; Fujita
et al. 2002; Ohta et al. 2003; Tatsumi et al. 2003; Oh-
saki et al. 2009). This suggests that when ORC1 is
expressed it becomes NM bound. However, it should
be borne in mind that NM attachment of ORC1
might be cell type dependent as one report shows
ORC1 as sensitive to extraction with DNase I in pro-
liferating NIH3T3 cells (Madine et al. 2000).
Other ORC subunits have also been detected in
NM fractions, specifically ORC2-5 in asynchronous
HeLa cells (Kreitz et al. 2001; Fujita et al. 2002; Ohta
et al. 2003) and ORCs 2, 4, 5, and 6 in Drosophila
melanogaster cells (Varma & Mishra 2011), although
again this may be cell type specific as little ORC2
was NM bound in Raji cells (Mendez & Stillman
2000).
Where temporal resolution was attempted,
ORC2-5 were enriched in the NM fraction in G1
(Kreitz et al. 2001) or from late G1, in HeLa cells
(Ohta et al. 2003). In both cases, this was at the same
time as ORC1 was expressed and NM bound. Fur-
thermore investigation in HeLa cells showed that
when ORC1 was depleted by RNAi, ORC2 was no
longer enriched in the NM fraction (Ohta et al.
2003). Therefore, NM binding of ORC may well be
dependent on ORC1.
Cell division cycle 6
The majority of investigations into the subnuclear
localization of the CDC6 protein have revealed a
proportion that is attached to the NM. This has been
noted in asynchronous HeLa cells, BJAB, BC3, and
HEK293 cells and is somewhat depleted in the
absence of ORC1 in FT210 cells (Fujita 1999; Fujita
et al. 2002; Ohta et al. 2003; Ohsaki et al. 2009).
However, little CDC6 was found to be NM bound
in NIH3T3 cells (Madine et al. 2000) or Raji cells
(Mendez & Stillman 2000). Where cell cycle phases
were investigated, CDC6 was present in the NM
fraction during G1 or early S-phase but not in G2/M
cells (Fujita et al. 1999; Ohsaki et al. 2009). There-
fore, it is clear that independent groups, using differ-
ent methods and cell lines, have shown ORC and
CDC6 to be at least transiently attached to the NM.
Chromatin licensing and DNA replication factor 1
Along with CDC6, CDT1 is essential for the
functional assembly of the MCM helicase complex
and replication origin licensing (Cook et al. 2004).
Few investigators have looked at NM attachment but
one report described recovery of CDT1 in the NM
fraction for BJAB, BC3, and HEK293 cells; this
occurred specifically in G1 phase but not S or G2/M
phases (Ohsaki et al. 2009). This suggests that CDT1
may be recruited to the NM but there is not
enough information available to draw generalized
conclusions.
Mini chromosome maintenance complex
The heterohexameric MCM complex is believed to
be the helicase responsible for unwinding DNA dur-
ing replication (Takisawa et al. 2000), but its relation-
ship with the NM is not as clear as for other pre-RC
components. The majority of MCM3 and MCM2 is
not NM bound in asynchronous HeLa cells (Todorov
et al. 1995; Fujita et al. 1997) with similar results for
MCM2, MCM3, and MCM5/7 in REF52 cells
(Cook et al. 2002), MCM3 in Raji cells (Mendez &
Stillman 2000), and MCM5 in NIH3T3 cells (Stoe-
ber et al. 1998). However, Burkhart et al. (1995)
report a small but significant fraction of MCM3 in
HeLa cells, which is not released by nuclease or high
salt extraction. There are also several reports identify-
ing MCM4, MCM2, MCM3, and MCM7 in NM
proteomic screens in human or Drosophila melanogaster
cell lines (Gerner et al. 2002; Mitulovic et al. 2004;
Varma & Mishra 2011). Although the majority of the
MCM complex does not appear to be NM bound it
is possible that the small amount of MCM protein in
NM preparations reflects a weak, transient association,
which is easily missed in bulk preparations from asyn-
chronous cells. Some circumstantial support for the
idea that attachment to the NM may be important
for MCM function comes from ORC1 or CDC6
depletion studies, in which immobilization of MCM
(on chromatin or NM) is prevented (Ohta et al.
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2003). Similarly, immobilization of ORC2-5 com-
plexes on chromatin is not sufficient for MCM2
loading in the absence of ORC1 (Ohta et al. 2003).
As ORC1 appears to recruit the rest of the ORC
complex to the NM, this begins to suggest that load-
ing of MCM2 occurs in that fraction.
Coordinators and regulators
A few proteins involved in the regulation of initiation
of DNA replication and cell cycle progression have
been studied in the context of the NM, including
cyclin E (Munkley et al. 2011), Rb (Mancini et al.
1994), and CIZ1 (Ainscough et al. 2007).
Our study of cyclin E has been revealing, because
it seeks to compare NM recruitment at different
developmental stages (Munkley et al. 2011). In fact
the NM attachment of cyclin E, a key regulator of
initiation of DNA replication, may serve as a case
study that goes some way to explain the differing
reports of NM attachment of other replication pro-
teins. We showed that a proportion of cyclin E is
NM bound in differentiated, noncancer primary and
established cell lines. However, in all but one of
eight cancer cell lines we investigated, no cyclin E
was observed in the NM fraction (Munkley et al.
2011). A similar distinction was seen between differ-
entiated cells and undifferentiated cells in mouse,
human, and Xenopus model systems, so that in all
cases cyclin E was easily extracted from progenitor
cells but resistant to extraction in differentiated
derivatives. This suggests that cyclin E is recruited to
the NM as cells differentiate, and that cancer cells
either originate from cells that have not recruited
cyclin E, or that cyclin E is released from the NM
as a consequence of one of the events that lead to
transformation. In fact, failure to recruit cyclin E
(and by implication, initiation) to the NM in undif-
ferentiated and cancer cells may be one of the fac-
tors that promote plasticity in response to extrinsic
or intrinsic signals.
Overall, the work outlined here suggests that all
three phases of DNA replication can occur in associa-
tion with the NM. However, this may not be true
for all cell types, making choice of experimental sys-
tem crucial when planning further work. For various
practical reasons, much of the analysis of DNA repli-
cation is undertaken with Xenopus eggs, or cancer cell
lines such as HeLa, sometimes leading to the conclu-
sion that NM immobilization may not be important
for DNA replication. We would argue that the
reported differences in nuclear organization in terms
of proteins and loop attachments between embryonic
systems and cancer cell lines on the one hand, and
noncancer, differentiated cells on the other, offers a
clear path forward.
Models
Here we consider models that attempt to explain
how DNA replication may be organized in relation
to the NM. Template DNA and DNA replication
enzymes must move relative to each other during
synthesis. It is still common to see depictions that
show the DNA replication machinery as an entity
that moves along the DNA strand. However, consid-
eration of the evidence (below) has lead to the sug-
gestion that the DNA replication machinery is static
and instead the DNA moves through these fixed sites
(Pardoll et al. 1980).
Replication factories
Replication foci or ‘factories’ can be visualized by
immuno-detection of replication enzymes, or by
following incorporation of nucleotide analogues into
nascent DNA. They are believed to be macromole-
cular assemblies populated by the enzymes that repli-
cate DNA, forming several hundred efficient factories
representing clusters of origins and that are activated
at the same time. The number of origins is thought
to be highly heterogeneous but to be an average of
5–6 per factory (Berezney et al. 2000; Frouin et al.
2003; and references therein). There is some reason
to think that clustering of origins may offer an energy
saving, as activation in near space may enable more
efficient processing due to locally higher concentra-
tions of factors (Frouin et al. 2003) (Fig. 2D). How-
ever, not all origins are activated at the same time in
S-phase. Some areas of the genome are replicated
early in S-phase while others are replicated later.
Replication foci from all temporal stages of S-phase
have been shown to be NM associated (Nakayasu &
Berezney 1989) complete with nascent DNA which
gradually moves out from each focus (Hozak et al.
1993, 1994), consistent with the concept of emanat-
ing loops. Cohesin is thought to help hold loops
together because it is present at origins, interacts with
the pre-RC, and its absence slows S-phase (Guillou
et al. 2010). These data indicate that the replication
machinery is located at NM attachment points at the
base of chromatin loops.
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Organization of chromatin loops
Chromatin loops were first thought to be purely
structural, giving way to more complex models with
functionality at the base of loops. Depending on
which direction researchers have approached this
problem, models tend to appear in one of two forms,
either a flower shaped factory of loops with little
consideration of the NM (Frouin et al. 2003), or
attachment to a NM at loop bases without represen-
tation of how these may come together into a factory
(Cook 1999; Ottaviani et al. 2008) (Fig. 2B,D).
We, and others (Cook 1999; Ottaviani et al. 2008;
Rivera-Mulia et al. 2011), hypothesize that recruit-
ment of origins to the NM is part of the process of
initiation (Fig. 2C). Recruitment appears to occur
after pre-RC formation, as much of this is laid down
at telophase in the mitotic cell cycle, yet origins
appear to be recruited later in G1-phase (Djeliova
et al. 2001b). When incorporating origin recruitment
into models, several show an origin located distally
on a loop, being recruited to the NM in late G1/
S-phase. As DNA is spooled through replication
factories, newly synthesized DNA is extruded as two
new loops, with their origins returning to their origi-
nal location (Cook 1999; Ottaviani et al. 2008). This
implies a transient shortening of loops as origin
attachments are made and a further transient shorten-
ing as DNA is reeled through replication machinery
following origin activation. To understand the impact
this would have on average loop size, and we must
consider whether origins are all recruited at the same
time because if this is not synchronous the effect on
loop size could be minimal. Djeliova et al. (2001a,b)
report that both an early and a late origin were
recruited to the NM during late G1 (described in
more detail above), suggesting that recruitment to the
NM is synchronous rather than temporally distributed
as for replication factory activation. However, analysis
of chromatin loop size by MFHR has revealed no
global loop remodeling between different phases of
the cell cycle (Jackson et al. 1990).
To reconcile the model with these observations,
we considered the consequences of recruitment of
origins that are more proximal to existing attachment
points, as proposed elsewhere (Rivera-Mulia et al.
2011). Recruitment of origins at the ‘top’ of loops
would cause a reduction in loop size by up to 50%,
but this would be the maximum observed. Recruit-
ment of origins closer to the existing S/MAR would
have less of an effect on loop size. For example,
recruitment of origins a quarter of the way ‘up’ a
loop would initially cause only a maximum of 12.5%
drop in loop size (Fig. 2C), and the closer the origin
is to an existing S/MAR the less the effect would be.
Recruitment of origins close to existing S/MARs
may preferentially occur, in which case a small
decrease in global loop size may be difficult to
observe and may explain why no decrease is reported
for late G1-phase.
Similarly, no decrease in loop size is reported for
S-phase despite a theoretical decrease, as the DNA is
reeled in towards the replication machinery at the
NM. This is perhaps not surprising given that origins
are not all activated at the same time but as part of an
organized temporal programe. Taken together, these
arguments go some way to explaining little global
impact on average chromatin loop size in either late
G1 or S-phase.
Similarities to transcription
Briefly, we highlight the data suggesting a role of the
NM in transcription, as conclusions from this similar
mechanism can be informative. There is a large array
of published work implicating the NM as the site for
transcription (summarised in Razin et al. 2011).
Nuclear skeleton preparations showed nascent RNA,
active RNA polymerase, and active genes in the
resistant fraction, with similar results from NM prepa-
rations (Jackson & Cook 1985; and references
therein). Consistent with this, several reports suggest
that attachment points are enriched at transcribed
genes (Jackson et al. 1996; Craig et al. 1997), with
loops of ~4 kb, in contrast to ~200 kb loops of inac-
tive chromatin (Bode et al. 2003), suggesting the
attachments have functional significance. A proteo-
mics screen of NM proteins returned many transcrip-
tion factors (Albrethsen et al. 2009), which have been
suggested to be MARBPs with binding sites poten-
tially increasing the probability of a S/MAR. FISH
to various genes showed transcriptionally active genes
exhibited a spot at the NM (increased attachment)
whereas transcriptionally inactive genes were
extended on loops (Gerdes et al. 1994). However,
this separation was less clear during S-phase when it
was suggested that the attachment pattern was then a
combination of effects of transcriptional status and
transient NM attachment during replication with
both gain and loss of attachments during this period
(Gerdes et al. 1994). Models proposed for transcrip-
tion, like replication, involve loops forming factories
(Cook 1999; Sutherland & Bickmore 2009), implying
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a degree of commonality in mechanisms, but also a
potential conflict of organization.
Nuclear changes in cancer and disease
As a common feature of cancer cells, changes in
nuclear architecture and morphology have long been
the basis for cancer diagnoses (reviewed in Zink et al.
2004). However, without a complete understanding
of nuclear architecture in normal cells it is difficult to
consider whether such changes are cause or conse-
quence of the dysregulation of cancer cells. In addi-
tion to genetic and epigenetic changes, there are
many other recorded changes in the organization of
genes, subnuclear domains, nonlinear DNA associa-
tions, and regulatory and macromolecular complexes
in cancer cells (reviewed extensively elsewhere, for
example, in Zaidi et al. 2007). This is also true for
several other diseases (reviewed in Bode et al. 2000;
Linnemann & Krawetz 2009a), including the thalas-
saemias where deletions often correspond with
S/MAR sites suggesting that a change in chromatin
loop attachment is a contributory factor (Bode et al.
2000). Changes in NM composition have been
described for cancer cells compared to noncancer
cells, with some exploited as the basis of diagnostic
tests (Zink et al. 2004; He et al. 2008; Albrethsen
et al. 2009; Lever & Sheer 2010; Munkley et al.
2011; and references therein). For example, a splice
variant of the NM protein CIZ1 is associated with
and can be detected in the blood of individuals with
early stage disease (Higgins et al. 2012). Splice vari-
ants or altered expression of CIZ1 have also been
reported to be associated with other cancers, includ-
ing medulloblastoma, breast cancer, and Ewing’s sar-
coma (Warder & Keherly 2003; den Hollander &
Kumar 2006; Rahman et al. 2007) and with other
disorders including Alzheimer disease, rheumatoid
arthritis, and cervical dystonia (Judex et al. 2003;
Dahmcke et al. 2008; Xiao et al. 2012), many of
which report alteration in subnuclear localization.
The MARBP SATB1 is linked to aggressive breast
cancers, (reviewed in Lever & Sheer 2010) while
SAF-B is inversely correlated with the proliferative
rate of tumors (reviewed in Lever & Sheer 2010). A
number of NM proteins (for example, RUNX, CIZ1
and cyclin E) have been reported to have an altered
localization in cancer cells, sometimes due to failure
to be recruited to the NM (Zaidi et al. 2007; Munk-
ley et al. 2011; Higgins et al. 2012).
We suggest that some of the dysregulation of cancer
cells may be a direct result of events such as these, with
DNA replication and transcription no longer spatially
constrained by attachment to the NM. NM composi-
tion and loop attachments have been observed to
change during differentiation and development (Get-
zenberg 1994; Munkley et al. 2011; Varma & Mishra
2011), leading to the idea that this may serve to ‘fix’
the developmental programe (Vassetzky et al. 2000;
Munkley et al. 2011). We suggest this fixing of cell
type specific characteristics such as transcriptional prog-
rame and replication timing is defective in cancer cells,
resulting in a partial reversal to a less specified, embry-
onic-like organization of chromatin.
Conclusions
The replication of DNA is fundamental to all cells, but
is often deregulated in cancer cells with dramatic con-
sequences. Data are amassing that suggest all stages of
DNA replication are located at the NM at least in
some cell types, and it is becoming clear that immobi-
lization of DNA machinery and the resultant mecha-
nisms of replication are likely to be an important
method of regulating DNA synthesis. DNA replication
should therefore not be considered alone, but in the
context of nuclear architecture, with many other pro-
cesses occurring at the same time and in the same
space, in connection with a nuclear substructure. The
NM can appear mysterious and elusive in detail, which
we suggest may reflect the model system of choice.
The available published work suggests that in dif-
ferentiated, noncancer cells, attachment of DNA and
proteins involved in DNA replication to a NM
occurs at specific times in the preparation for and
during DNA replication. This is likely to constrain
the process in time and space and possibly help to
establish a heritable pattern of DNA replication.
Attachment to a spatially constrained structure would
also promote efficient use of required factors, with
locally high concentrations at specific sites rather than
diffusely spread throughout the nucleus. However,
using the behavior of cyclin E as an indicator, we
suggest that in undifferentiated or cancer cells initia-
tion of DNA replication is less fixed in space. We
suggest that failure to constrain initiation may allow
greater flexibility and plasticity in these cell types, and
that such flexibility may be lost with the imposition
of spatial constraint as cells differentiate. This idea
echoes the change in origin usage recorded as cells
differentiate, with random and more frequent origin
usage in early embryonic cell cycles, giving way to
fewer and more specified origin usage in later cell
cycles. Many other fundamental processes also appear
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to occur at the NM, such as transcription, DNA
repair and epigenetic remodeling. Therefore, it is
likely that these may also be subject to a similar level
of regulation as DNA replication and their disregula-
tion in cancer may similarly be in part due to com-
promised attachment to the NM.
As well as these potential differences between cell
types we should also bear in mind that there may
well be different mechanisms occurring within one
cell. While there appears a universal process of DNA
synthesis, it is likely that there will be differences in
the initiation process. For example, there may be
slightly different mechanisms used to select and
initiate origins that govern replication through
euchromatin compared to heterochromatin.
In conclusion we suggest that the relationship
between the NM and DNA replication is important
and complex, providing organization in many forms
as well as anchoring key processes. However, this
relationship cannot at the moment be generalized
with differences occurring between cell types, and we
hypothesize different types of chromatin within the
same cell.
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Chapter 
The nuclear matrix: preparation for microscopy and biochemical analysis 
Topic introduction 
The nuclear matrix: fractionation techniques and analysis  
Short title: Nuclear matrix fractionation 
Wilson, R. H. C.1* Hesketh, E.1 and Coverley, D.1 
1 Department of Biology, University of York, Wentworth Way, York, YO10 5DD, UK 
* Corresponding author: Wilson, R. H. C. rhcw500@york.ac.uk, 01904 328569 
The first descriptions of an insoluble nuclear structure appeared more than 70 years ago, but it is only 
in recent years that a sophisticated picture of its significance has begun to emerge. In this article we 
explain multiple methods for the study of the nuclear matrix. These have led to the understanding that 
the nuclear matrix consists of core components that are consistently present, such as matrins, lamins, 
hnRNPs and other ‘structural’ proteins, and conditional proteins that are recruited into the nuclear 
matrix to facilitate specific processes (Mika and Rost 2005). These include components of the DNA 
replication machinery (reviewed in Wilson & Coverley 2013), transcription machinery (Jackson and 
Cook 1985), DNA repair (Qiao et al. 2001; Boisvert et al. 2005; Campalans et al. 2007), splicing 
(Zeitlin et al. 1987; Jagatheesan et al. 1999) and chromatin remodelling (Reyes et al. 1997) as well as 
a catalogue of proteins identified by proteomic analysis (Albrethsen et al. 2009). In most cases the 
functional significance of their immobilisation remains an area of study, nevertheless, a number of 
nuclear matrix proteins are already gaining credibility as clinically useful biomarkers (Keesee et al. 
1999; Subong et al. 1999; Van Le et al. 2004; Higgins et al. 2012). 
A brief history 
Descriptions of a protein fraction that is resistant to extraction under high salt conditions were first 
made in 1942 (reviewed in Pederson 1998). However, the term ‘nuclear matrix’ was first used in 1974 
to refer to those proteins resistant to extraction with 2.0 M NaCl (Berezney and Coffey 1974). 
‘Nuclear matrix’ has become widely adopted as an overarching term for the proteins that resist 
aggressive methods of extraction, and we use it as such here. The 2.0 M NaCl method has been 
criticised because of its potential to cause aggregation of proteins. This led to the development of 
more refined extraction methods including lithium 3,5-diiodosalicylate (LIS), which was first used by 
Mirkovitch et al. (1984) to reveal a protein fraction termed the nuclear scaffold, and extraction after 
encapsulation in agarose under physiologically relevant salt concentrations (Jackson and Cook 1988) 
to reveal a substructure known as the nuclear skeleton (or nucleoskeleton). Further variations and 
refinement of these techniques have also been used (reviewed in Martelli et al. 2002). A modification 
of the original nuclear matrix method was developed by Capco et al (1982), which reduced the 
potential for aggregation by using more physiologically relevant buffers with lower salt (0.5 M NaCl) 
and used nucleases (DNase I or other enzymes) to digest chromatin into small diffusible fragments. 
This was termed the ‘in situ nuclear matrix’ as the cytoskeleton is also maintained under these 
conditions. Extraction with 2.0 M NaCl has subsequently been termed the ‘core nuclear matrix’. 
 
A simple picture? 
Despite the range of approaches used, some controversies have remained and reviews of the evidence 
for and against the nuclear matrix have come to conflicting conclusions (Pederson 1998; Hancock 
2000; Nickerson 2001; Martelli et al. 2002). It has proved difficult to visualise the filamentous 
structure revealed by electron microscopy, using immunofluorescence-light microscopy, which 
typically reveal punctate foci for most of the 100s of nuclear matrix proteins that have been described. 
However it should be bourn in mind that the proteins which fractionate with the nuclear matrix and 
are identified by proteomic analysis may in fact make up highly dynamic ‘local’ matrices rather than 
one large static structure (Martelli et al. 2002). 
One fundamental biological reason for the debate surrounding existence and nature of the nuclear 
matrix may in fact be that it exists in different forms in different cell types and may even be absent in 
some instances. We and others have shown that nuclear matrix composition varies dramatically with 
differentiation and disease status and that some proteins are actively recruited as part of normal 
cellular transitions (Getzenberg 1994; Zink et al. 2004; Munkley et al. 2011; Varma and Mishra 
2011). Thus a lot of work previously undertaken on cancer cell lines, embryonic cells or Xenopus 
eggs must now be interpreted in this light to avoid clouding the picture in normal somatic cells 
(Munkley et al. 2011). There remains a need for a resurgence in nuclear matrix investigation that 
includes comparative analysis, the protocols that we use for this purpose accompany this topic 
introduction (The nuclear matrix: preparation protocol for parallel microscopy and biochemical 
analysis, Wilson et al. 2013).  
Approaches to functional analysis (for schematic see figure 1) 
Electron microscopy 
The resolution of the electron microscope has allowed detailed visualisation of the fibrilar protein 
network within the nucleus of higher eukaryotic cells (Capco et al. 1982; Fey et al. 1986; Jackson and 
Cook 1988). It has been viewed after RNase digestion (Berezney and Coffey 1974), DNase digestion 
(Capco et al. 1982), removal of chromatin by electroelution (Jackson and Cook 1988) and in a range 
of buffer conditions designed to minimise artefacts (Mirkovitch et al. 1984; Jackson and Cook 1988; 
Nickerson et al. 1997; Engelhardt 1999; Wan et al. 1999). The nuclear matrix has also been viewed in 
paraformaldehyde fixed sections of unextracted nuclei, identifying protein rich inter chromosomal 
areas consistent with the description of a NM (Hendzel et al. 1999).  
Proteomic analysis 
Studies to identify the component parts of the nuclear matrix were compiled in a database of Nuclear 
Matrix Proteins, NMPdb (Mika and Rost 2005). Since then, large-scale proteomic screens have been 
undertaken which compare nuclear matrix components enriched in tumour cells and at different 
developmental stages (Albrethsen et al. 2009; Albrethsen et al. 2010; Varma & Mishra 2011 and 
references therein for methods).  
Analysis of attached DNA  
The proteinaceous structure isolated by nuclear matrix extraction protocols is associated with residual 
DNA as well as RNA. Attachment of DNA was first observed by electron microscopy in the 1970s 
(Paulson and Laemmli 1977). Various methods have since been used to study the attached DNA, 
including digestion of chromatin loops with restriction enzymes, DNase I or topoisomerase II to 
reveal the attachment points (Mirkovitch et al. 1984; Djeliova et al. 2001; Linnemann et al. 2009; 
Rivera-Mulia et al. 2011), followed by isolation and sequencing, labelling by FISH, or by 
incorporation of nucleotide analogues. DNA that remains attached after extraction with high salt are 
termed MARs (matrix attached region), and those remaining following extraction for the scaffold or 
skeleton are known respectively, as SARs (scaffold attached region), or skeleton-attached sequences. 
The possible functional significance of these classes of attachment has been reviewed previously 
(Wilson & Coverley 2013). 
Related protocols (Maximum Fluorescence Halo Radius) that extract histones and loosely attached 
proteins, but which leave chromatin undigested have been used to study the DNA loops that emanate 
from the attachment points on the nuclear matrix (Vogelstein et al. 1980; Gerdes et al. 1994; Lemaitre 
et al. 2005; Guillou et al. 2010). A method combining nuclear matrix extraction with chromosome 
conformation capture (3C) has also recently been developed, termed M3C (Gavrilov et al. 2010).  
Analysis by CSK protocol 
The following method describes the protocol that we prefer to use for the analysis of nuclear matrix 
related functions. This incorporates serial extraction with non-ionic detergent (Triton–X-100) to 
remove membranes and soluble proteins under physiologically relevant salt concentrations, followed 
by 0.5 M NaCl, then DNase I digestion and removal of fragmented DNA. Complimentary analysis by 
immunoblotting and immunofluorescence reveals information on isoforms and on spatial 
organisation. The protocol uses cytoskeletal (CSK) buffer to stabilise the cytoskeleton and nuclear 
matrix in relatively gentle conditions. CSK was first used by Lenk et al. (1977) and later by Capco et 
al. (1982) for electron microscopy. Others have used it for immuno-detection of individual nuclear 
matrix components (Nickerson et al. 1992; Grondin et al. 1996; Huang et al. 2004; Boisvert et al. 
2005; Ainscough et al. 2007; Campalans et al. 2007), identification of protein domains required for 
nuclear matrix binding (Ainscough et al. 2007), analysis of temporally regulated recruitment (Fujita 
1999; Fujita et al. 2002; Miccoli et al. 2003; Samaniego et al. 2006; Sree et al. 2012), and to compare 
recruitment between developmental or differentiation stages and between disease states (Munkley et 
al. 2011). The benefits of this method include the relatively gentle buffer conditions, potential to 
generate robust results by using imaging and biochemical analysis in parallel, and its flexibility to 
incorporate high salt to reveal the core nuclear matrix, or pre-treatment with a protein-protein 
crosslinker to reveal those proteins only weakly associated with the nuclear matrix. It can also be 
combined with other cellular manipulations for specific questions, such as cell synchrony protocols, 
depletion by RNAi and expression of ectopic proteins. Together, these offer the potential to uncover 
the functional relevance of recruitment to the nuclear matrix. 
Acknowledgements: 
Work in this laboratory is supported by the Biotechnology and Biological Sciences Research Council, 
UK and Yorkshire Cancer Research, UK. 
References: 





.+-* U2"V23* 7!* 2C* /8>* ?@H@>* 1'4#'%82/3* E3&C2&0"%$* "#* %&8&32%C/8* %/#%23J* "62#C"F"%/C"&#* &F*
!"#$%&'() %'"&*+%,) &') $+%) '-*.%/")0/$"&1) 2"/*$&#') /',) "%3-./$&#') &') /,%'#0/) $#) */"*&'#0/)
!"#3"%((&#'4)!"#$%&##$'(")&"*+,-)!5)67789::;4)
<%"%='%>) ?@) A#22%>) BC4) 96DE4) F,%'$&2&*/$&#') #2) /) '-*.%/") !"#$%&') 0/$"&14) .+",/&*$ .+"0/1-$ 2&-$
%"**34)"#5)9E9:89E9D4)
<#&(G%"$)HI@)J%',=%.)IK@)I/((#') KL@)?&*+/",)C4)M::;4)I%$+>./$&#')#2)I?N99) "%3-./$%() &$()'-*.%/")
*#0!/"$0%'$/.&=/$&#'4)%&##$%1,#&)$5)67986764)
A/0!/./'() O@) O0#-"#-1) ?@) <"/G/",) O@) N!%) <@) ?/,&*%../) KP4) M::D4) QRO) &""/,&/$&#') &',-*%()
"%.#*/.&(/$&#')#2) $+%)BSO)"%!/&")!"#$%&')+TUU9)$#)'-*.%/")(!%*V.%(4) 5"3(46#$"7$%&##$8,+&4,&)
%&#5)MW8WM4)
A/!*#) BU@) X/') YI@) P%'0/') C4) 967M4) Z+%) '-*.%/") 0/$"&15) $+"%%8,&0%'(&#'/.) /"*+&$%*$-"%) /',)
!"#$%&')*#0!#(&$&#'4)%&##)&!5)7ED87;74)




H%>) NU@) Y"#*+0/.'&*) U@) P%'0/') C4) 967^4) Z+%) '#'*+"#0/$&') (-\($"-*$-"%() #2) $+%) '-*.%-(5) $+%)











U%",%() IU@) A/"$%") YA@) I#%') PZ@) K"4@) c/]"%'*%) K<4) 966E4) B>'/0&*) *+/'3%() &') $+%) +&3+%"8.%G%.)




U"#',&') <@) </=&'%$)I@)O-\">)I4) 966^4) Z+%) Y?O<) =&'*) 2&'3%") 3%'%) bSHDE) %'*#,%() /')?SO8\&',&'3)
!"#$%&') $&3+$.>) /((#*&/$%,) ]&$+) $+%) '-*.%/") 0/$"&14) 5"3(46#$ "7$ .+"#"=+,6#$ %/&*+-)(1) &(%5)
9;E;789;E^D4)










84) 96774)R&(-/.&=/$&#')#2) /) 2&./0%'$#-()'-*.%#(V%.%$#')]&$+) /) MW)'0)/1&/.) "%!%/$4)B*D"$ 5)(5) W^^D8
W^DD4)
K/3/$+%%(/') U@) Z+/'-0/./>/') C@) I-"/.&V"&(+'/) <@) ?/'3/"/[) S@) Y/"/',%) OO@) P/"'/&V) RY4) 96664)
A#.#*/.&=/$&#') #2) &'$"/'-*.%/") ./0&') 2#*&) ]&$+) ?SO) (!.&*&'3) 2/*$#"(4) 5"3(46#$ "7$ %&##$ 8,+&4,&)
%%&5)E^;98E^^94)
!""#""$%!&$'"(")$*+&$,-./012#32$'+&$4156#$7%&$%0"".#$77&$'6)/0"#"$*&$8)"9")$:&$;3.<$=&$>-$?*@$ABBB@$
;)"/C121/6C$ D"6#151C1.($ #.-E($ 3D$ F';AGB&$ 6$ 2-/C"6)$ H6.)1I$ 9)3."12$ H6)J")$ D3)$ /")K1/6C$
E(#9C6#16@$!"#$%&'#()$!"L$AMANOAMPP@$
+"H61.)"$ *'&$=621#$ 7&$ ;6#")3$;&$Q6##".<J($?&$'"/06C1$'@$PMMN@$'1.3.1/$ )"H3E"C12R$3D$ .0"$ )"9C1/32$
62E$/0)3H3#3H"$#.)-/.-)"@$&*))$#$"L$GSGOSMA@$










'1)J3K1./0$ *&$ '1)6-C.$ '7&$ +6"HHC1$ `!@$ ABSX@$ 8)R621<6.132$ 3D$ .0"$ 01R0")O3)E")$ /0)3H6.12$ C339L$
#9"/1D1/$=F:$6..6/0H"2.$#1."#$32$2-/C"6)$#/6DD3CE@$&*))$"(L$PP^OP^P@$
'-2JC"($*&$439"C62E$F:&$'31R26)E$Q&$!21R0.$*T&$])"6K"#$7&$T6H#53..3H$%:&$;3U26CC$'7&$%3-.0R6."$
*&$ :12#/3-R0$ *Y&$ 43K")C"($ =@$ PMAA@$ 4(/C12$ 7$ 1#$ )"/)-1."E$ .3$ .0"$ 2-/C"6)$ H6.)1I$ E-)12R$
E1DD")"2.16.132&$5-.$1#$23.$)"/)-1."E$12$/62/")$/"CC#@$5,")*1"%!"162%7*2$"(L$PVGAOPVGG@$
F1/J")#32$*@$PMMA@$7I9")1H"2.6C$35#")K6.132#$3D$6$2-/C"6)$H6.)1I@$9%&*))%:"1$##!L$XV^OXGX@$
F1/J")#32$ *:&$ !)3/JH6C21/$ ]&$ >62$ !'&$ ;"2H62$ %@$ ABBG@$ \0"$ 2-/C"6)$ H6.)1I$ )"K"6C"E$ 5($ "C-.12R$
/0)3H6.12$D)3H$6$/)3##OC12J"E$2-/C"-#@$;8("**610<2%(=%#4*%5$#1(0$)%!"$6*-'%(=%:"1*0"*2%(=%
#4*%>01#*6%:#$#*2%(=%!-*81"$$(!L$XXXVOXXNM@$
F1/J")#32$ *:&$ !)3/JH6C21/$ ]&$ >62$ !'&$ \-)2")$ 4=&$ ;"2H62$ %@$ ABBP@$ :$ 23)H6CC($ H6#J"E$ 2-/C"6)$

















%-532R$ 7F&$ %0-"$'*&$ 79#."12$ *_&$ [)1RRH62$ *Q&$ 4062$ ;!&$ ;6).12$:>@$ ABBB@$'323/C326C$ 62.153E($ .3$
9)3#.6."$/62/")$2-/C"6)$H6.)1I$9)3."12$d;T8LXOPAVe$)"/3R21<"#$2-/C"3903#H12W[P^@$;8(2#$#*$
"(L$PBSO^MX@$














Figure legends:  






Can reveal differential behaviour of isoforms 












































The nuclear matrix: preparation protocol for parallel microscopy and 
biochemical analysis 
Short title: Nuclear matrix protocol 
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Abstract 
The immobilisation of nuclear proteins is usually investigated using extraction with detergent to 
reveal attachment to insoluble structures. This is often assumed to be chromatin and is described as 
such in many studies. However, the detergent resistant protein fraction consists of both chromatin-
bound and nuclear matrix-bound proteins. To further separate these fractions DNA should be removed 
and the remaining proteins visualised in comparison to those in unextracted cells. We describe two 
related protocols that identify nuclear matrix proteins by immunofluorescence (IF) or immuoblotting 
(IB). IB has the advantage of resolving different forms of a protein of interest and includes analysis of 
soluble fractions excluded by the IF protocol. IF analysis has the advantage of allowing individual 
cells to be monitored rather than homogenised populations and can be performed on very low quantity 
samples. Analysis by IF will also reveal the spatial arrangement of proteins bound to residual nuclear 
structures. These methods have been used by many labs to study nuclear matrix proteins (Nickerson et 
al. 1992; Blencowe et al. 1994; Fujita et al. 1997) and by our laboratory to determine protein domains 
required for nuclear matrix binding (Ainscough et al. 2007), shifts in protein localisation during 
biological transitions (Munkley et al. 2011), and absence from the nuclear matrix fraction in diseased 
states (Munkley et al. 2011). 
Reagents 
Cells grown on coverslips or cytospun onto slides (IF), or one 15 cm plate of adherent cells at > 50% 
confluent density (IB)  
For transfected cells, first evaluate the transfection protocol for destabilizing effects on the nuclear 
matrix. 
Cytoskeletal buffer (CSK) and derivatives. Filter sterilise and store basic buffer in 50 ml aliquots at -
20°C <R> 
DNase I, and buffer recommended by supplier 
Determine optimal concentration, digestion time and temperature using release of DNA (IF) or 
chromatin bound proteins such as histone (IB) as indicator. This will vary with cell type, is unlikely to 
be 100% efficient and will not release MAR DNA. DNase must be RNase free (eg Roche, 
04716728001). Test by incubation with prepared RNA and visualisation of products after 
electrophoresis. 
Hoechst or DAPI DNA counterstain (IF) 
Use at 0.1 µg/ml and keep constant to allow establishment of imaging conditions. 
Mounting medium (IF) 
Paraformaldehyde (PFA) 4% <R> (IF) 
Phosphate buffered saline (PBS) 
PMSF – 200 mM stock in ethanol, stored at -20°C (IB) 
Primary antibody to protein of interest and secondary antibody for detection.  
Concentration and conditions should be established using cells extracted with detergent. These 
represent a mid-point between unextracted and chromatin-depleted cells with which imaging 
parameters can be determined.  
SDS loading buffer (4x) – standard Laemmli recipe (IB) 
Sodium chloride – 5 M stock 
Triton X-100 – at 1% 
Equipment 
13 mm glass coverslips (IF) 
15 cm culture plates (IB) 
24 well culture plates (IF) 
Cell scraper (IB) 
Fine forceps and hooked needle for moving coverslips (IF) 
Fluorescent microscope with 63 x oil immersion objective and image capture system (IF) 
Gel electrophoresis and Western blotting equipment (IB) 
Glass slides (IF) 
Heat block at 95°C (IB) 
Humidified chamber such as a plastic box with sealable lid (IF) 
Incubator at 37°C 
Parafilm (IF) 
Refridgerated microcentrifuge (IB) 
Vortex (IB) 
Method   
1. Thaw CSK, add supplements as required. See table 1 for volumes <R>. Keep all buffers on ice. 
DNase I should be kept at -20°C until required.  
A. Immunofluorescence  
2A. Transfer cells on coverslips to PBS in 24 well plates (3-4 per sample).  
Coverslips are processed throughout with cells uppermost. Coverslips can be moved between wells to 
change buffer, or buffers can be gently changed by pipette.  
Coverslips are processed to reveal i) total protein (no extraction), ii) detergent-resistant proteins 
(immobilised by attachment to insoluble structures), iii) high-salt and DNase resistant proteins 
(bound to the nuclear matrix), iv) optional high-salt resistant proteins (tightly bound to chromatin or 
the nuclear matrix). For a summary of the method see figure 1A. 
3A. Transfer coverslip i into 4% PFA (10 minutes, RT). Move to PBS and store at 4°C.  
4A. Move remaining coverslips to CSKb (1 minute, RT). Move ii to PBS and prepare for IF as 3A. 
5A. Move remaining coverslips to CSKc (1 minute, RT).  
6A. Wash coverslips twice in DNase buffer (1 minute, RT). 
Wash step reduces salt concentration in preparation for DNase treatment. 
7A. Place coverslips on parafilm in humidified chamber. For iii add DNase I in DNase buffer, or for 
iv buffer only (20 !l per coverslip). Seal and incubate using optimised time and temperature.  
Humidify chamber to prevent drying out by including a reservoir of sterile water (e.g. damp tissue). 
8A. Move coverslips to CSKc (1 minute, RT), then PBS and prepare for IF as 3A. 
9A. Coverslips should be processed as soon as possible using standard immunofluorescence 
protocols, and imaged using high-resolution fluorescence microscopy and appropriate image capture 
system. 
Blocking agents such as BSA should be of ELISA grade and protease and RNase free (eg. Jackson 
001-000-162). The contrast between treated and untreated samples should be verified by imaging, 
using the minimum effective concentration of DNA counterstain and constant image capture 
parameters (e.g. 10-20 ms). A dramatic reduction in DNA counterstain should be evident for DNase 
treated coverslips, though a small amount of DNA will remain. Immunostaining conditions and 
imaging should be kept constant across a sample set (e.g. 200-400 ms). DNase treated nuclei from 
which the protein of interest is also extracted can be hard to spot. In these cases use an RNA 
counterstain such as propidium iodide or co-stain for a nuclear structure protein, such as lamin B2. 
An example image is shown in figure 1B. 
B. Immunoblotting  
2B. Rinse plate with PBS, then twice with CSKa. Remove and drain plates for 2 mins at 45° on ice. 
Remove excess buffer then scrape harvest cells (recover ~200 µl per 15 cm plate). Measure the 
volume, add 2 mM PMSF and TX100 to 0.1% final concentration. Divide equally between four 500 
!l eppendorfs (i, ii, iii, iv) and record volume (1 x vol).  
Samples will be processed to reveal cell equivalents of ‘T’ total protein, ‘det P’ detergent-resistant 
pellet (proteins immobilised by attachment to insoluble structures), ‘det SN’ detergent-soluble 
supernatant, ‘w’ 0.5 M NaCl-soluble supernatant, ‘DNase P’ DNase-resistant pellet (bound to the 
nuclear matrix), ‘DNase SN’ DNase-sensitive supernatant  (bound to chromatin), ‘mock P’, high-salt 
resistant pellet (tightly bound to chromatin or the nuclear matrix) and ‘mock SN’ (released during 
control incubation). For a summary of the method see figure 1A. 
3B. To i (T), add 1/3 volume of 4 x SDS loading buffer. Vortex, heat to 95°C for 5 minutes and store 
at -20°C. 
4B. After 2 minutes on ice, centrifuge ii, iii and iv at 6800g (2 minutes, 4 °C). Transfer supernatant 
from ii to a fresh tube (det SN) and resuspend pellet ii in 1 x vol CSKb (det P). Prepare both for SDS-
PAGE as 3B. 
5B. Discard supernatant from iii and iv. Resuspend pellets in 1 x vol CSKc (2 minutes on ice) and 
centrifuge at 6800g (3 minutes, 4 °C). Recover supernatant from iii to a fresh tube (w). Prepare for 
SDS-PAGE as 3B. Discard supernatant from iv.  
6B. Resuspend pellets iii and iv in ~ 100 !l DNase buffer. Centrifuge 9500g, (3 minutes, 4 °C). 
Discard supernatants. 
7B. Resuspend pellets iii and iv in 1 x vol DNase buffer, add DNase I to iii and incubate both tubes 
using optimised amount, time and temperature.  
8B. Add 1/10 volume 5 M NaCl to both tubes and incubate for 5 minutes. Centrifuge 9500g (5 
minutes, 4 °C), transfer supernatants from tubes iii and iv to fresh tubes (DNase SN and mock SN). 
Resuspend pellets in 1 x vol DNase buffer (DNase P and mock P). Prepare these samples for SDS-
PAGE as 3B. 
Pellets iii and iv are very ‘sticky’ and can get stuck in the pipette tip. Resuspend by vortexing. 
9B. Samples can be processed using standard SDS-PAGE and western blotting protocols.  
In addition to the protein of interest, blots should be probed with a control antibody against a 
chromatin bound protein that is released when chromatin is digested (eg. histone H3). If studying a 
protein that is not normally nuclear matrix-bound a second control antibody should be used that 
detects an insoluble component of the nucleus (eg. lamin B2). A successful DNase extraction would be 
expected to release >75% of histone H3 into the DNase supernatant fraction, while retaining all 
histone H3 in the pellet fraction of the mock treated sample. Loss of histone from this fraction 
indicates contamination of buffers, or loss or degradation of residual nuclei. An example image is 
shown in figure 1C. 
Troubleshooting 
Problem: DNA or protein is not released from DNase treated sample 
Solution: Optimise DNase conditions and take care to remove high-salt buffer prior to digestion. For 
IB, mix digestion reaction periodically during incubation to ensure resuspension of pellet, and take 
care to mix after NaCl addition (step 8B).   
Problem: Absence of expected antigen in DNase treated samples. 
Solution: Buffers may be contaminated with proteases or RNases, both of which will degrade (part 
of) the nuclear matrix. Buffers should be remade, possibly with RNase inhibitors and equipment 
cleaned. Check for presence of a protein known to be nuclear matrix bound such as lamin B2. 
Related Information  
The nuclear matrix can also be revealed by the use of 2.0 M NaCl – the ‘core’ nuclear matrix. The 
protocol can be adapted to use high-salt treatments instead of DNase extraction. Keeping all the cell 
lysate in a single tube, follow Immunoblot protocol to step 2B, then proceed by resuspending pellet in 
CSKb supplemented with increasing NaCl. Repeat with 100mM stepwise increases in NaCl up to 1M, 
collecting each supernatant and the final pellet as separate samples (Ainscough et al. 2007).  
Alternatively, the protocol can be adapted to reveal proteins associated with the nuclear matrix but 
less tightly bound. In this case a protein-protein cross-linker such as DTSP can be used before 
extraction to preserve protein complexes. For method see (Fujita et al. 1999).  
For further information regarding alternative methods for extracting the nuclear matrix, see The 
nuclear matrix: fractionation techniques and analysis (Wilson et al. 2013). 
Recipes: 
<R>  Components Recipe (per 50ml) Vol per 3 sets of 
4 coverslips (IF) 












Immediately before use 
add:- 
1mM DTT 
Protease inhibitor cocktail 
(eg Roche, 05 056 489 001) 
0.5ml of 1M  
1ml of 5M  
5.135g  
0.2ml of 250mM  









b Add  
0.1% Triton X-100 







c Add  
0.1% Triton X-100 
0.5M NaCl 
0.5ml of 10% 
TX100  
4ml of 5M 
2ml 1ml 
PFA  4% paraformaldehyde 
50mM HEPES/KOH 7.8 
 
2g 
2.5ml of 1M stock 
6ml - 
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Figure 1. A. Flow diagram to represent in situ nuclear matrix extraction using Immunofluorescence 
and Immunoblot (P = pellet, SN = supernatant). B. Images show CIZ1 protein (red, detected with !-
CIZ1 1793, Coverley et al. 2005) in unextracted nuclei from murine 3T3 cells (total) and after 
extraction to reveal detergent resistant, or DNase I resistant fractions. Nuclei are counterstained with 
Hoechst H33258 (blue). Bar=10 mm. C. Western blot of protein fractions derived from murine 3T3 
cells showing total protein (T), and detergent resistant (P), detergent soluble (SN), 0.5M salt sensitive 
(w), DNase I resistant (P), DNase I soluble fractions (SN), and mock incubation in the absence of 
DNase I. CIZ1 (Novus Biologicals 74623) is detected in the DNase pellet fraction revealing it to be a 
nuclear matrix protein. The presence of lamin B2 (Abcam: ab151735) in DNase pellet confirms the 
nuclear matrix fraction, and extent of histone H3 release (Abcam: ab1791) into the DNase I SN 






CSK 0.5 M NaCl!
i. Total ! PBS!
ii. Detergent resistant !
DNase buffer wash!
DNase I or mock incubation!
CSK 0.5 M NaCl!
4 % PFA!
PBS!





High salt sensitive (w)!





iii. DNase I resistant!
(P, nuclear matrix) !
iv. Mock DNase I resistant!
(P, chromatin/nuclear matrix)!
DNase I soluble !
(SN, tightly chromatin bound)!
Mock soluble!
(SN, should be blank)!
iv. High salt resistant !
(chromatin/nuclear matrix)!







CSK 0.1 % Tx100!
Total! Detergent!








P   SN ! w!
DNase! Mock!
P   SN ! P   SN !
Det.!
T!
